# EDGAR Filing Document

**Accession Number:** 0001489393
**File Stem:** 0001489393-25-000041
**Filing Date:** 2025-8
**Character Count:** 172222
**Document Hash:** 45c4987efefe86879aa03dc9f5552faa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001489393-25-000041.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001489393-25-000041

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 81

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250801

**DATE AS OF CHANGE**: 20250801

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LyondellBasell Industries N.V.
- **CENTRAL INDEX KEY:** 0001489393
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL ORGANIC CHEMICALS [2860]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980646235
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34726
- **FILM NUMBER:** 251175167

**BUSINESS ADDRESS:**
- **STREET 1:** 1221 MCKINNEY ST
- **STREET 2:** SUITE 300
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77010
- **BUSINESS PHONE:** 713-309-7603

**MAIL ADDRESS:**
- **STREET 1:** 1221 MCKINNEY ST
- **STREET 2:** SUITE 300
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77010

?xml version='1.0' encoding='ASCII'? lyb-20250630

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025** 

**or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>to<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Commission file number: 001-34726** 

**LYONDELLBASELL INDUSTRIES N.V.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| | **Netherlands** | **98-0646235** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **2800 Post Oak Blvd.** | **2800 Post Oak Blvd.** | **4th Floor, One Vine Street** | | |
| **Suite 5100** | **Suite 5100** | **London** | **Delftseplein 27E** | **Delftseplein 27E** |
| **Houston,** | **Texas** | **W1J0AH** | **3013AA** | **Rotterdam** |
| **USA** | **77056** | **United Kingdom** | **Netherlands** | **Netherlands** |

---

**(Address of principal executive offices) (Zip code)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **(713)** | **309-7200** | **+44 (0)** | **207** | **220 2600** | **+31 (0)**<sub>10</sub> | **275 5500** |

---

**(Registrant's telephone numbers, including area code)**

  

**(Former name, former address and former fiscal year, if changed since last report)**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of Each Class</u>** | **<u>Trading Symbol</u>** | **<u>Name of Each Exchange On Which Registered</u>** |
| **Ordinary Shares, €0.04 Par Value** | **LYB** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ⌧&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ⌧&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ⌧ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

The registrant had 321,648,429 ordinary shares, €0.04 par value, outstanding at July 30, 2025 (excluding 18,774,069 treasury shares).

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | **<u>Page</u>** |
| <u>[Part I – Financial Information](#i3e1ae353f0754b77ac381f1934c5c699_10)</u> | [1](#i3e1ae353f0754b77ac381f1934c5c699_10) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Consolidated Financial Statements (Unaudited)](#i3e1ae353f0754b77ac381f1934c5c699_13)</u> | [1](#i3e1ae353f0754b77ac381f1934c5c699_13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Income](#i3e1ae353f0754b77ac381f1934c5c699_16)</u> | [1](#i3e1ae353f0754b77ac381f1934c5c699_16) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Comprehensive Income](#i3e1ae353f0754b77ac381f1934c5c699_19)</u> | [2](#i3e1ae353f0754b77ac381f1934c5c699_19) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Balance Sheets](#i3e1ae353f0754b77ac381f1934c5c699_22)</u> | [3](#i3e1ae353f0754b77ac381f1934c5c699_22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows](#i3e1ae353f0754b77ac381f1934c5c699_28)</u> | [5](#i3e1ae353f0754b77ac381f1934c5c699_28) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Shareholders' Equity](#i3e1ae353f0754b77ac381f1934c5c699_31)</u> | [7](#i3e1ae353f0754b77ac381f1934c5c699_31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to the Consolidated Financial Statements](#i3e1ae353f0754b77ac381f1934c5c699_37)</u> | [9](#i3e1ae353f0754b77ac381f1934c5c699_37) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#i3e1ae353f0754b77ac381f1934c5c699_94)</u> | [31](#i3e1ae353f0754b77ac381f1934c5c699_94) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#i3e1ae353f0754b77ac381f1934c5c699_151)</u> | [47](#i3e1ae353f0754b77ac381f1934c5c699_151) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4. Controls and Procedures](#i3e1ae353f0754b77ac381f1934c5c699_154)</u> | [48](#i3e1ae353f0754b77ac381f1934c5c699_154) |
| <u>[Part II – Other Information](#i3e1ae353f0754b77ac381f1934c5c699_157)</u> | [49](#i3e1ae353f0754b77ac381f1934c5c699_157) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1. Legal Proceedings](#i3e1ae353f0754b77ac381f1934c5c699_160)</u> | [49](#i3e1ae353f0754b77ac381f1934c5c699_160) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 1A. Risk Factors](#i3e1ae353f0754b77ac381f1934c5c699_163)</u> | [49](#i3e1ae353f0754b77ac381f1934c5c699_163) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#i3e1ae353f0754b77ac381f1934c5c699_166)</u> | [49](#i3e1ae353f0754b77ac381f1934c5c699_166) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 4. Mine Safety Disclosures](#i3e1ae353f0754b77ac381f1934c5c699_169)</u> | [50](#i3e1ae353f0754b77ac381f1934c5c699_169) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 5. Other Information](#i3e1ae353f0754b77ac381f1934c5c699_172)</u> | [50](#i3e1ae353f0754b77ac381f1934c5c699_172) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Item 6. Exhibits](#i3e1ae353f0754b77ac381f1934c5c699_175)</u> | [51](#i3e1ae353f0754b77ac381f1934c5c699_175) |
| <u>[Signature](#i3e1ae353f0754b77ac381f1934c5c699_178)</u> | [52](#i3e1ae353f0754b77ac381f1934c5c699_178) |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**PART I. FINANCIAL INFORMATION**

**ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

 **LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED STATEMENTS OF INCOME**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars, except earnings per share</u>** | **2025** | **2024** | **2025** | &nbsp;&nbsp;&nbsp;&nbsp;**2024** |
| **Sales and other operating revenues:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade | $7503 | $8518 | $15031 | $16654 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Related parties | 155 | 160 | 304 | 328 |
|  | 7658 | 8678 | 15335 | 16982 |
| **Operating costs and expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 6871 | 7244 | 13999 | 14444 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairments | 32 |  | 32 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 435 | 402 | 836 | 823 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development expenses | 35 | 33 | 69 | 65 |
|  | 7373 | 7679 | 14936 | 15332 |
| **Operating income** | 285 | 999 | 399 | 1650 |
| Interest expense | (118) | (120) | (225) | (247) |
| Interest income | 21 | 37 | 51 | 78 |
| Gain on sale of business |  | 293 |  | 293 |
| Other income, net | 29 | 9 | 50 | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before equity investments and income taxes | 217 | 1218 | 275 | 1788 |
| Income (loss) from equity investments | 7 | (19) | 8 | (46) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before income taxes | 224 | 1199 | 283 | 1742 |
| Provision for income taxes | 69 | 253 | 105 | 363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations | 155 | 946 | 178 | 1379 |
| (Loss) income from discontinued operations, net of tax | (40) | (22) | 114 | 18 |
| **Net income** | 115 | 924 | 292 | 1397 |
| Dividends on redeemable non-controlling interests | (1) | (1) | (3) | (3) |
| Net income attributable to the Company shareholders | $114 | $923 | $289 | $1394 |
| **Earnings per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net income (loss) attributable to the Company shareholders —** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $0.47 | $2.89 | $0.53 | $4.21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | (0.13) | (0.07) | 0.35 | 0.05 |
|  | $0.34 | $2.82 | $0.88 | $4.26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $0.47 | $2.88 | $0.53 | $4.20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | (0.13) | (0.06) | 0.35 | 0.05 |
|  | $0.34 | $2.82 | $0.88 | $4.25 |

---

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** |
| Net income | $115 | $924 | $292 | $1397 |
| Other comprehensive income (loss), net of tax – |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial derivatives | (35) | 49 | (6) | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined benefit pension and other postretirement benefit plans | 2 | 4 | (4) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translations | 127 | (44) | 189 | (104) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss), net of tax | 94 | 9 | 179 | (47) |
| Comprehensive income | 209 | 933 | 471 | 1350 |
| Dividends on redeemable non-controlling interests | (1) | (1) | (3) | (3) |
| Comprehensive income attributable to the Company shareholders | $208 | $932 | $468 | $1347 |

---

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| **<u>Millions of dollars</u>** | **June 30,<br>2025** | **December 31,<br>2024** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $1700 | $3375 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 4 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade, net | 3083 | 3121 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Related parties | 122 | 171 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 4568 | 4658 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 767 | 928 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale | 832 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 11076 | 12266 |
| Operating lease assets | 1506 | 1467 |
| Property, plant and equipment | 25588 | 24174 |
| Less: Accumulated depreciation | (9861) | (9108) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 15727 | 15066 |
| Equity investments | 4080 | 4121 |
| Goodwill | 1677 | 1561 |
| Intangible assets, net | 572 | 577 |
| Other assets | 714 | 688 |
| Total assets | $35352 | $35746 |

---

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| **<u>Millions of dollars, except shares and par value data</u>** | **June 30,<br>2025** | **December 31,<br>2024** |
| **LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS AND EQUITY** | | |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | $495 | $498 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term debt | 119 | 119 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade | 2630 | 3220 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Related parties | 483 | 512 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 1950 | 2356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liabilities held for sale | 567 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 6244 | 6705 |
| Long-term debt | 11211 | 10532 |
| Operating lease liabilities | 1407 | 1419 |
| Other liabilities | 1919 | 1967 |
| Deferred income taxes | 2536 | 2535 |
| Commitments and contingencies |  |  |
| Redeemable non-controlling interests | 114 | 114 |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary shares, €0.04 par value, 1,275 million shares authorized, 321,627,610 and 323,889,832 shares outstanding, respectively | 19 | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 6139 | 6150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 8732 | 9325 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (1353) | (1532) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost, 18,794,888 and 16,532,666 ordinary shares, respectively | (1628) | (1500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Company share of shareholders' equity | 11909 | 12462 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-controlling interests | 12 | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 11921 | 12474 |
| Total liabilities, redeemable non-controlling interests and equity | $35352 | $35746 |

---

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $292 | $1397 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 655 | 752 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairments | 32 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt-related costs | 5 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 55 | 53 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity investments— |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity (income) loss | (8) | 46 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Distributions of earnings, net of tax | 18 | 40 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax benefit | (30) | (55) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business |  | (293) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities that provided (used) cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (81) | (604) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (85) | (335) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (433) | 373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (648) | (145) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) provided by operating activities | (228) | 1234 |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenditures for property, plant and equipment | (1022) | (967) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition of equity method investments | (8) | (512) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of business |  | 700 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from settlement of net investment hedges | 284 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for settlement of net investment hedges | (234) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 46 | (44) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | $(934) | $(823) |

---

&nbsp;&nbsp;&nbsp;&nbsp;

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchases of Company ordinary shares | $(201) | $(75) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid - common stock | (878) | (846) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of long-term debt | 499 | 744 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments of debt issuance costs | (5) | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of long-term debt |  | (775) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from settlement of cash flow hedges |  | 882 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for settlement of cash flow hedges |  | (835) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (13) | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (598) | (893) |
| Effect of exchange rate changes on cash | 76 | (59) |
| **Decrease in cash and cash equivalents and restricted cash** | (1684) | (541) |
| Cash and cash equivalents and restricted cash at beginning of period | 3388 | 3405 |
| Cash and cash equivalents and restricted cash at end of period | $1704 | $2864 |

---

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

 **LYONDELLBASELL INDUSTRIES N.V.**

**CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Ordinary Shares** | **Ordinary Shares** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| **<u>Millions of dollars</u>** | **Issued** | **Treasury** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| Balance, March 31, 2025 | $19 | $(1559) | $6132 | $9064 | $(1447) | $12209 | $12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  | 115 |  | 115 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  | 94 | 94 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation |  | 22 | 7 | (3) |  | 26 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - common stock ($1.37 per share) |  |  |  | (443) |  | (443) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - redeemable non-controlling interests ($15.00 per share) |  |  |  | (1) |  | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchases of Company ordinary shares |  | (91) |  |  |  | (91) |  |
| Balance, June 30, 2025 | $19 | $(1628) | $6139 | $8732 | $(1353) | $11909 | $12 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Ordinary Shares** | **Ordinary Shares** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| **<u>Millions of dollars</u>** | **Issued** | **Treasury** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| Balance, March 31, 2024 | $19 | $(1372) | $6112 | $9752 | $(1532) | $12979 | $14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  | 924 |  | 924 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  | 9 | 9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation |  | 45 | 10 | (4) |  | 51 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - common stock ($1.34 per share) |  |  |  | (438) |  | (438) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - redeemable non-controlling interests ($15.00 per share) |  |  |  | (1) |  | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchases of Company ordinary shares |  | (75) |  |  |  | (75) |  |
| Balance, June 30, 2024 | $19 | $(1402) | $6122 | $10233 | $(1523) | $13449 | $14 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Ordinary Shares** | **Ordinary Shares** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| **<u>Millions of dollars</u>** | **Issued** | **Treasury** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| Balance, December 31, 2024 | $19 | $(1500) | $6150 | $9325 | $(1532) | $12462 | $12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  | 292 |  | 292 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  | 179 | 179 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation |  | 73 | (11) | (4) |  | 58 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - common stock ($2.71 per share) |  |  |  | (878) |  | (878) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - redeemable non-controlling interests ($30.00 per share) |  |  |  | (3) |  | (3) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchases of Company ordinary shares |  | (201) |  |  |  | (201) |  |
| Balance, June 30, 2025 | $19 | $(1628) | $6139 | $8732 | $(1353) | $11909 | $12 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Ordinary Shares** | **Ordinary Shares** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| **<u>Millions of dollars</u>** | **Issued** | **Treasury** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Company<br>Share of<br>Shareholders'<br>Equity** | **Non-<br>Controlling<br>Interests** |
| Balance, December 31, 2023 | $19 | $(1450) | $6145 | $9692 | $(1476) | $12930 | $14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income |  |  |  | 1397 |  | 1397 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive loss |  |  |  |  | (47) | (47) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation |  | 123 | (23) | (7) |  | 93 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - common stock ($2.59 per share) |  |  |  | (846) |  | (846) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends - redeemable non-controlling interests ($30.00 per share) |  |  |  | (3) |  | (3) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchases of Company ordinary shares |  | (75) |  |  |  | (75) |  |
| Balance, June 30, 2024 | $19 | $(1402) | $6122 | $10233 | $(1523) | $13449 | $14 |

---

See Notes to the Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **<u>Page</u>** |
| 1. | <u>[Basis of Presentation](#i3e1ae353f0754b77ac381f1934c5c699_40)</u> | [10](#i3e1ae353f0754b77ac381f1934c5c699_40) |
| 2. | <u>[Accounting and Reporting Changes](#i3e1ae353f0754b77ac381f1934c5c699_43)</u> | [10](#i3e1ae353f0754b77ac381f1934c5c699_43) |
| 3. | <u>[Discontinued Operations](#i3e1ae353f0754b77ac381f1934c5c699_46)</u> | [11](#i3e1ae353f0754b77ac381f1934c5c699_46) |
| 4. | <u>[Assets Held for Sale](#i3e1ae353f0754b77ac381f1934c5c699_196)</u> | [11](#i3e1ae353f0754b77ac381f1934c5c699_196) |
| 5. | <u>[Revenues](#i3e1ae353f0754b77ac381f1934c5c699_52)</u> | [12](#i3e1ae353f0754b77ac381f1934c5c699_52) |
| 6. | <u>[Accounts Receivable](#i3e1ae353f0754b77ac381f1934c5c699_55)</u> | [13](#i3e1ae353f0754b77ac381f1934c5c699_55) |
| 7. | <u>[Inventories](#i3e1ae353f0754b77ac381f1934c5c699_58)</u> | [13](#i3e1ae353f0754b77ac381f1934c5c699_58) |
| 8. | <u>[Debt](#i3e1ae353f0754b77ac381f1934c5c699_61)</u> | [14](#i3e1ae353f0754b77ac381f1934c5c699_61) |
| 9. | <u>[Financial Instruments and Fair Value Measurements](#i3e1ae353f0754b77ac381f1934c5c699_67)</u> | [17](#i3e1ae353f0754b77ac381f1934c5c699_67) |
| 10. | <u>[Income Taxes](#i3e1ae353f0754b77ac381f1934c5c699_73)</u> | [20](#i3e1ae353f0754b77ac381f1934c5c699_73) |
| 11. | <u>[Commitments and Contingencies](#i3e1ae353f0754b77ac381f1934c5c699_76)</u> | [21](#i3e1ae353f0754b77ac381f1934c5c699_76) |
| 12. | <u>[Shareholders' Equity and Redeemable Non-controlling Interests](#i3e1ae353f0754b77ac381f1934c5c699_82)</u> | [22](#i3e1ae353f0754b77ac381f1934c5c699_82) |
| 13. | <u>[Per Share Data](#i3e1ae353f0754b77ac381f1934c5c699_85)</u> | [25](#i3e1ae353f0754b77ac381f1934c5c699_85) |
| 14. | <u>[Segment and Related Information](#i3e1ae353f0754b77ac381f1934c5c699_88)</u> | [27](#i3e1ae353f0754b77ac381f1934c5c699_88) |

---

&nbsp;&nbsp;&nbsp;&nbsp;

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

**1.&nbsp;&nbsp;&nbsp;&nbsp;Basis of Presentation**

LyondellBasell Industries N.V. is a limited liability company (Naamloze Vennootschap) incorporated under Dutch law by deed of incorporation dated October 15, 2009. Unless otherwise indicated, the "Company," "we," "us," "our" or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries ("LyondellBasell N.V."). LyondellBasell N.V. is a worldwide manufacturer of chemicals and polymers, a producer of gasoline blending components and a developer and licensor of technologies for the production of polymers.

The accompanying unaudited Consolidated Financial Statements have been prepared from the books and records of LyondellBasell N.V. in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X for interim financial information. Certain notes and other information have been condensed or omitted from the interim financial statements included in this report. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States ("U.S. GAAP") for complete financial statements. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. In the opinion of management, all adjustments, including normal recurring adjustments, considered necessary for a fair statement have been included. These statements contain some amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The results for interim periods are not necessarily indicative of results for the entire year.

In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation. The related operating results of our refining business are reported as discontinued operations for all periods presented.

**2.&nbsp;&nbsp;&nbsp;&nbsp;Accounting and Reporting Changes**

**Recently Adopted Guidance**

There were no new standards or Accounting Standard Updates ("ASU") adopted in the six months ended June 30, 2025, that had a material impact on the Consolidated Financial Statements.

**Accounting Guidance Issued But Not Adopted as of June 30, 2025**

*Expense Disaggregation Disclosures*—In November 2024, the FASB issued ASU 2024-03, *Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.* This guidance requires incremental disclosures about specific expense categories, including but not limited to, purchases of inventory, employee compensation, depreciation, amortization and selling expenses. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. While permitted, we do not plan to early adopt this guidance. The guidance may be applied either prospectively or retrospectively. The adoption of this ASU will not have a material impact on our Consolidated Financial Statements as the guidance relates only to disclosure.

*Income Tax Disclosures*—In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures.* The guidance requires companies to disclose certain specific categories in the rate reconciliation and provide additional information for reconciling items that meet the quantitative threshold of 5% of the expected tax using the applicable statutory income tax rate. There is also a required disclosure to provide the net income taxes paid or received disaggregated by federal, state, and foreign taxes with jurisdictions to be separately disclosed if the jurisdiction is 5% or more of the total net income taxes paid or received. The guidance is effective for annual periods beginning after December 15, 2024. We will adopt the new guidance for our Income Tax Disclosures in the 2025 annual period. The adoption of this ASU will not have a material impact on our Consolidated Financial Statements as the guidance relates only to disclosure.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

**3.&nbsp;&nbsp;&nbsp;&nbsp;Discontinued Operations**

The following table presents components of (Loss) income from discontinued operations, net of tax:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** |
| Sales and other operating revenues | $326 | $2345 | $1525 | $4435 |
| Cost of sales | 369 | 2369 | 1370 | 4401 |
| Selling, general and administrative expenses | 2 | 5 | 4 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | (45) | (29) | 151 | 25 |
| Other (expense) income, net | (2) | 3 | (2) | 1 |
| (Benefit from) provision for income taxes | (7) | (4) | 35 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Loss) income from discontinued operations, net of tax | $(40) | $(22) | $114 | $18 |

---

**4.&nbsp;&nbsp;&nbsp;&nbsp;Assets Held for Sale**

*Proposed European Asset Sale—*In June 2025, we entered into an agreement for the sale of select olefins & polyolefins assets and the associated business in Europe. The sites to be sold have been part of the previously announced European strategic assessment and are located in Berre l'Etang (France), Münchsmünster (Germany), Carrington (United Kingdom), and Tarragona (Spain). The sites identified for sale are within our Olefins & Polyolefins-Europe, Asia, International ("O&P-EAI") segment. The agreement is a put option deed under which the purchaser has committed to enter into an agreed form purchase agreement if we exercise our put option, after conclusion of certain works council consultation processes.

Closing of the proposed transaction is currently expected in the first half of 2026, subject to the completion of the information and consultation processes with the relevant employee representative bodies in accordance with applicable laws, as well as regulatory and other customary closing conditions. The assets and liabilities associated with the business to be sold have been classified as held for sale in the Consolidated Balance Sheets as of June 30, 2025.

In connection with the sale, we expect to recognize a loss on sale of approximately $700 million to $900 million upon closing. The loss principally consists of the transfer of net working capital of approximately $340 million, a cash contribution of $300 million to the sold businesses prior to closing, a foreign currency translation adjustment of approximately $300 million to $400 million, and a net equity method investment of approximately $10 million, partially offset by the transfer of pension and other liabilities of $150 million to $250 million.

Other costs, including selling expenses, separation costs, and employee-related costs, of approximately $100 million to $150 million, are estimated to be incurred prior to closing. During the second quarter of 2025, we incurred $10 million of such costs in connection with this transaction.

During the second quarter of 2025, a non-cash impairment loss of $32 million was recognized and allocated to property, plant and equipment. The fair value of the disposal group was determined based on the expected consideration and other fair value indicators obtained through our marketing efforts and classified as Level 2 within the fair value hierarchy. The impairment charge is presented within Impairments in the Consolidated Statements of Income.

*U.S. Specialty Powders Business—*In the second quarter of 2025, we entered into an agreement to sell our U.S. specialty powders business for a total consideration of approximately $10 million, subject to working capital and other adjustments. The transaction is expected to close in the second half of 2025 and is subject to customary closing conditions. The business had been identified as a non-core business within our Advanced Polymer Solutions ("APS") segment.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

The following table summarizes the assets and liabilities held for sale in the Consolidated Balance Sheets:

---

| | | | |
|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| **<u>Millions of dollars</u>** | **European Assets** | **U.S. Specialty Powders Business** | **Total** |
| **ASSETS** | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable - Trade, net | $345 | $— | $345 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 399 | 10 | 409 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 30 |  | 30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease assets | 10 | 7 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity investments | 29 |  | 29 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill |  | 2 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets held for sale | $813 | $19 | $832 |
| **LIABILITIES** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable - Trade | $207 | $— | $207 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 112 | 1 | 113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 7 | 6 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 219 | 1 | 220 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 14 |  | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities held for sale | $559 | $8 | $567 |

---

**5.&nbsp;&nbsp;&nbsp;&nbsp;Revenues**

*Contract Balances—*Contract liabilities were $146 million and $117 million as of June 30, 2025 and December 31, 2024, respectively. Revenue recognized in each reporting period that was included in the contract liability balance at the beginning of the period was immaterial.

*Disaggregation of Revenues—*The following table presents our revenues disaggregated by key products:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** |
| Sales and other operating revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Olefins and co-products | $933 | $1317 | $1999 | $2562 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Polyethylene | 1882 | 1942 | 3660 | 3840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Polypropylene | 1565 | 1577 | 3103 | 3075 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Propylene oxide and derivatives | 556 | 630 | 1144 | 1232 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oxyfuels and related products | 1151 | 1431 | 2282 | 2541 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intermediate chemicals | 511 | 667 | 1052 | 1456 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compounding and solutions | 913 | 943 | 1817 | 1903 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 147 | 171 | 278 | 373 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $7658 | $8678 | $15335 | $16982 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

The following table presents our revenues disaggregated by geography, based upon the location of the customer:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** |
| Sales and other operating revenues: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States | $2654 | $3177 | $5509 | $6344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Germany | 557 | 663 | 1173 | 1323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;China | 480 | 535 | 960 | 1141 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mexico | 400 | 432 | 809 | 868 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Italy | 359 | 393 | 686 | 794 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Japan | 286 | 360 | 604 | 594 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;France | 298 | 301 | 563 | 558 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Poland | 210 | 247 | 413 | 489 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Netherlands | 228 | 214 | 394 | 399 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2186 | 2356 | 4224 | 4472 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $7658 | $8678 | $15335 | $16982 |

---

**6.&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable**

Accounts receivable are reflected in the Consolidated Balance Sheets, net of allowance for credit losses of $3 million and $4 million as of June 30, 2025 and December 31, 2024, respectively.

**7.&nbsp;&nbsp;&nbsp;&nbsp;Inventories**

Inventories consisted of the following components:

---

| | | |
|:---|:---|:---|
| **<u>Millions of dollars</u>** | **June 30,<br>2025** | **December 31, 2024** |
| Finished goods | $2963 | $3014 |
| Work-in-process | 126 | 145 |
| Raw materials and supplies | 1479 | 1499 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total inventories | $4568 | $4658 |

---

During the first six months of 2025, inventory liquidations associated with our exit from the refinery business generated a last-in, first-out ("LIFO") benefit of $196 million, net of tax, or $0.60 per diluted share. This benefit is reflected in (Loss) income from discontinued operations, net of tax in the Consolidated Statements of Income. No material inventory liquidations were recognized during the three months ended June 30, 2025, or the six months ended June 30, 2024.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

**8.&nbsp;&nbsp;&nbsp;&nbsp;Debt**

Long-term loans, notes and other debt, net of unamortized discount, debt issuance cost and cumulative fair value hedging adjustments, consisted of the following:

---

| | | |
|:---|:---|:---|
| **<u>Millions of dollars</u>** | **June 30,<br>2025** | **December 31,<br>2024** |
| Senior Notes due 2055, $1,000 million, 4.625% ($15 million of discount; $10 million of debt issuance cost) | $975 | $975 |
| Guaranteed Notes due 2027, $300 million, 8.1% | 300 | 300 |
| **Issued by LYB International Finance B.V.:** | **Issued by LYB International Finance B.V.:** | **Issued by LYB International Finance B.V.:** |
| Guaranteed Notes due 2043, $750 million, 5.25% ($17 million of discount; $6 million of debt issuance cost) | 727 | 726 |
| Guaranteed Notes due 2044, $1,000 million, 4.875% ($9 million of discount; $8 million of debt issuance cost) | 983 | 983 |
| **Issued by LYB International Finance II B.V.:** | **Issued by LYB International Finance II B.V.:** | **Issued by LYB International Finance II B.V.:** |
| Guaranteed Notes due 2026, €500 million, 0.875% ($1 million of debt issuance cost) | 582 | 515 |
| Guaranteed Notes due 2027, $1,000 million, 3.5% ($1 million of discount; $1 million of debt issuance cost) | 588 | 584 |
| Guaranteed Notes due 2031, €500 million, 1.625% ($3 million of discount; $2 million of debt issuance cost) | 579 | 514 |
| **Issued by LYB International Finance III LLC:** | **Issued by LYB International Finance III LLC:** | **Issued by LYB International Finance III LLC:** |
| Guaranteed Notes due 2025, $500 million, 1.25%  | 490 | 487 |
| Guaranteed Notes due 2030, $500 million, 3.375% ($1 million of debt issuance cost) | 128 | 123 |
| Guaranteed Notes due 2030, $500 million, 2.25% ($2 million of discount; $3 million of debt issuance cost) | 479 | 473 |
| Guaranteed Notes due 2033, $500 million, 5.625% ($5 million of debt issuance cost) | 495 | 495 |
| Guaranteed Notes due 2034, $750 million, 5.5% ($5 million of discount, $6 million of debt issuance cost) | 739 | 738 |
| Guaranteed Notes due 2035, $500 million, 6.150% ($1 million of discount, $5 million of debt issuance cost | 494 |  |
| Guaranteed Notes due 2040, $750 million, 3.375% ($1 million of discount; $7 million of debt issuance cost) | 742 | 742 |
| Guaranteed Notes due 2049, $1,000 million, 4.2% ($13 million of discount; $10 million of debt issuance cost) | 977 | 976 |
| Guaranteed Notes due 2050, $1,000 million, 4.2% ($6 million of discount; $10 million of debt issuance cost) | 984 | 982 |
| Guaranteed Notes due 2051, $1,000 million, 3.625% ($2 million of discount; $10 million of debt issuance cost) | 941 | 918 |
| Guaranteed Notes due 2060, $500 million, 3.8% ($4 million of discount; $5 million of debt issuance cost) | 486 | 482 |
| Other | 17 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 11706 | 11030 |
| Less current maturities | (495) | (498) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt | $11211 | $10532 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

Fair value hedging adjustments associated with the fair value hedge accounting of our fixed-for-floating interest rate swaps for the applicable periods are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Gains (Losses)** | **Gains (Losses)** | **Gains (Losses)** | **Gains (Losses)** | **Cumulative Fair Value<br>Hedging Adjustments Included<br>in Carrying Amount of Debt** | **Cumulative Fair Value<br>Hedging Adjustments Included<br>in Carrying Amount of Debt** |
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **June 30,** | **December 31,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| Guaranteed Notes due 2025, 1.25% | $(1) | $(1) | $(3) | $(1) | $1 | $4 |
| Guaranteed Notes due 2026, 0.875% | (1) |  | (1) |  | 3 | 4 |
| Guaranteed Notes due 2027, 3.5% | (1) |  | (3) | 4 | 2 | 5 |
| Guaranteed Notes due 2030, 3.375% | (2) |  | (5) | 3 | 13 | 18 |
| Guaranteed Notes due 2030, 2.25% | (2) |  | (5) | 3 | 16 | 21 |
| Guaranteed Notes due 2031, 1.625% | (1) | 1 | 1 | 2 | 2 | 1 |
| Guaranteed Notes due 2050, 4.2% | (1) | (1) | (2) | (3) |  | 2 |
| Guaranteed Notes due 2051, 3.625% | (9) | (1) | (23) | 10 | 47 | 70 |
| Guaranteed Notes due 2060, 3.8% | (2) |  | (4) | 3 | 5 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $(20) | $(2) | $(45) | $21 | $89 | $134 |

---

Fair value adjustments are recognized in Interest expense in the Consolidated Statements of Income.

***Long-Term Debt***

*Senior Revolving Credit Facility*—Our $3,750 million senior unsecured revolving credit facility (the "Senior Revolving Credit Facility"), which expires in July 2029, may be used for dollar and euro denominated borrowings. The facility also supports our commercial paper program, has a $200 million sub-limit for dollar and euro denominated letters of credit and a $1,000 million uncommitted accordion feature. Borrowings under the facility bear interest at either a base rate, secured overnight financing rate or EURIBOR rate, plus an applicable margin. Additional fees are incurred for the average daily unused commitments. As of June 30, 2025, we had no borrowings or letters of credit outstanding and $3,750 million of unused availability under this facility.

*Guaranteed Notes due 2035*—In May 2025, LYB International Finance III, LLC ("LYB Finance III"), a wholly owned finance subsidiary of LyondellBasell Industries N.V., issued $500 million of 6.150% guaranteed notes due 2035 (the "2035 Notes") at a discounted price of 99.7%. Net proceeds after deducting original issuance discounts, underwriting fees and offering expenses totaled $494 million. Net proceeds from the sale of the notes are used for general corporate purposes, including the repayment of our 2025 Notes.

These unsecured notes, which are fully and unconditionally guaranteed by LyondellBasell Industries N.V., rank equally in right of payment to all of LYB Finance III's and LyondellBasell Industries N.V.'s existing and future senior unsecured indebtedness and will rank senior in right of payment to any future subordinated indebtedness that LYB Finance III or LyondellBasell Industries N.V. incurs. There are no significant restrictions that would impede LyondellBasell Industries N.V., as guarantor, from obtaining funds by dividend or loan from its subsidiaries. The indenture governing these notes contains limited covenants, including those restricting our ability, and the ability of our subsidiaries, to incur indebtedness secured by significant property or by capital stock of subsidiaries that own significant property, enter into certain sale and lease-back transactions with respect to any significant property or enter into consolidations, mergers or sales of all or substantially all of our assets.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

The 2035 Notes may be redeemed at any time in whole, or from time to time in part, prior to the scheduled maturity date, at a redemption price equal to the greater of (i) the sum of the present values of the remaining scheduled payments of principal and interest (discounted at the treasury rate plus the applicable basis points) less interest accrued on the notes to be redeemed, and (ii) 100% of the principal amount of the notes redeemed; plus, in either case, accrued and unpaid interest thereon to, but excluding, the redemption date. The 2035 Notes may also be redeemed at any time, on or after the date that is three months prior to the scheduled maturity date of the notes at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued and unpaid interest thereon to, but excluding, the redemption date. The notes are also redeemable upon certain tax events.

***Short-Term Debt***

*U.S. Receivables Facility*—Our U.S. Receivables Facility has a purchase limit of $900 million in addition to a $300 million uncommitted accordion feature. In May 2025, we extended the term of the facility to June 2026. This facility provides liquidity through the sale or contribution of trade receivables by certain of our U.S. subsidiaries to a wholly owned, bankruptcy-remote subsidiary on an ongoing basis and without recourse. We pay variable interest rates on our secured borrowings. Additional fees are incurred for the average daily unused commitments. This facility also provides for the issuance of letters of credit up to $200 million. As of June 30, 2025, we had no borrowings or letters of credit outstanding and $900 million unused availability under this facility.

*Commercial Paper Program*—We have a commercial paper program under which we may issue up to $2,500 million of privately placed, unsecured, short-term promissory notes ("commercial paper"). As of June 30, 2025, we had no borrowings of outstanding commercial paper.

*Precious Metal Financings*—At both June 30, 2025 and December 31, 2024, we had $119 million of Short-term debt related to our precious metal financings.

*Weighted Average Interest Rate*—As of June 30, 2025 and December 31, 2024, our weighted average interest rates on outstanding Short-term debt were 1.6% and 1.1%, respectively.

***Additional Information***

*Debt Compliance*—As of June 30, 2025, we are in compliance with our debt covenants.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

**9.&nbsp;&nbsp;&nbsp;&nbsp;Financial Instruments and Fair Value Measurements**

We are exposed to market risks, such as changes in commodity pricing, interest rates and currency exchange rates. To manage the volatility related to these exposures, we selectively enter into derivative contracts pursuant to our risk management policies.

*Financial Instruments Measured at Fair Value on a Recurring Basis*—The following table summarizes financial instruments outstanding for the periods presented that are measured at fair value on a recurring basis:

---

| | | | |
|:---|:---|:---|:---|
| | **Fair Value** | **Fair Value** | |
| **<u>Millions of dollars</u>** | **June 30, 2025** | **December 31, 2024** |<br>**Balance Sheet Classification** |
| **Assets–** | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives designated as hedges: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | $3 | $14 | Prepaid expenses and other current assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | 9 | 7 | Other assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | 11 | 146 | Prepaid expenses and other current assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency |  | 66 | Other assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rates | 18 | 16 | Prepaid expenses and other current assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives not designated as hedges: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | 6 | 18 | Prepaid expenses and other current assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities |  | 2 | Other assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | 1 | 16 | Prepaid expenses and other current assets |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $48 | $285 |  |
| **Liabilities–** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives designated as hedges: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | $20 | $14 | Accrued and other current liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | 1 | 5 | Other liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | 103 | 9 | Accrued and other current liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | 147 |  | Other liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rates | 26 | 36 | Accrued and other current liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rates | 102 | 146 | Other liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives not designated as hedges: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | 35 | 11 | Accrued and other current liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | 20 | 1 | Accrued and other current liabilities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $454 | $222 |  |

---

The financial instruments in the table above are classified as Level 2. We present the gross assets and liabilities of our derivative financial instruments on the Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

*Financial Instruments Not Measured at Fair Value on a Recurring Basis*—The following table presents the carrying value and estimated fair value of our short-term precious metal financings and Long-term debt:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| **<u>Millions of dollars</u>** | **Carrying<br> Value** | **Fair<br> Value** | **Carrying<br> Value** | **Fair <br>Value** |
| Precious metal financings | $119 | $149 | $119 | $122 |
| Long-term debt | 11199 | 9697 | 10521 | 9048 |
| Total | $11318 | $9846 | $10640 | $9170 |

---

The financial instruments in the table above are classified as Level 2. Our other financial instruments classified within Current assets and Current liabilities have a short maturity and their carrying value approximates fair value.

*Derivative Instruments:*

*Commodity Prices*—The following table presents the notional amounts of our outstanding commodity derivative instruments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Notional Amount** | **Notional Amount** | **Unit of Measure** | **Maturity Date** |
| **<u>Millions of units</u>** | **June 30, 2025** | **December 31, 2024** | **Unit of Measure** | **Maturity Date** |
| Derivatives designated as hedges: | Derivatives designated as hedges: | Derivatives designated as hedges: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Natural gas | 60 | 62 | MMBtu | 2025 to 2028 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ethane | 14 | 14 | Bbls | 2025 to 2028 |
| &nbsp;&nbsp;&nbsp;&nbsp;Power | 1 |  | MWhs | 2025 to 2028 |
| Derivatives not designated as hedges: | Derivatives not designated as hedges: | Derivatives not designated as hedges: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Ethane | 21 |  | Bbls | 2025 to 2026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other commodities | 3 | 6 | Bbls | 2025 to 2026 |

---

*Interest Rates*—The following table presents the notional amounts of our outstanding interest rate derivative instruments:

---

| | | | |
|:---|:---|:---|:---|
| | **Notional Amount** | **Notional Amount** | |
| **<u>Millions of dollars</u>** | **June 30, 2025** | **December 31, 2024** |<br>**Maturity Date** |
| Fair value hedges | $2035 | $2158 | 2025 to 2031 |

---

*Foreign Currency Rates*—The following table presents the notional amounts of our outstanding foreign currency derivative instruments:

---

| | | | |
|:---|:---|:---|:---|
| | **Notional Amount** | **Notional Amount** | |
| **<u>Millions of dollars</u>** | **June 30, 2025** | **December 31, 2024** |<br>**Maturity Date** |
| Net investment hedges | $2779 | $3256 | 2025 to 2030 |
| Cash flow hedges | 294 | 300 | 2027 |
| Not designated | 1115 | 772 | 2025 to 2026 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

*Impact on Earnings and Other Comprehensive Income (Loss)*—The following tables summarize the pre-tax effect of derivative instruments recorded in Accumulated other comprehensive income ("AOCI"), the gains (losses) reclassified from AOCI to earnings and additional gains (losses) recognized directly in earnings:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** |
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** |
| | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Income Statement** | **Income Statement** | |
| | **Gain (Loss)<br>Recognized in<br>AOCI** | **Gain (Loss)<br>Recognized in<br>AOCI** | **Gain (Loss) Reclassified <br>to Income <br>from AOCI** | **Gain (Loss) Reclassified <br>to Income <br>from AOCI** | **Additional Gain<br>(Loss) Recognized<br>in Income** | **Additional Gain<br>(Loss) Recognized<br>in Income** | **Income Statement** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** | **Classification** |
| Derivatives designated as hedges: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | $— | $(1) | $— | $1 | $— | $— | Sales and other operating revenues |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | (49) | 31 | 4 | 35 |  |  | Cost of sales |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | (273) | 25 | 24 | 1 | 13 | 14 | Interest expense |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rates |  |  | 1 | 1 | 7 | (17) | Interest expense |
| Derivatives not designated as hedges: | Derivatives not designated as hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities |  |  |  |  | (17) | 5 | Cost of sales |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities |  |  |  |  |  | 13 | (Loss) income from discontinued operations, net of tax |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency |  |  |  |  | (52) | 16 | Other income, net |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $(322) | $55 | $29 | $38 | $(49) | $31 |  |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** | **Effects of Financial Instruments** |
| | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Income Statement** | **Income Statement** | |
| | **Gain (Loss)<br>Recognized in<br>AOCI** | **Gain (Loss)<br>Recognized in<br>AOCI** | **Gain (Loss) Reclassified <br>to Income <br>from AOCI** | **Gain (Loss) Reclassified <br>to Income <br>from AOCI** | **Additional Gain<br>(Loss) Recognized<br>in Income** | **Additional Gain<br>(Loss) Recognized<br>in Income** | **Income Statement** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** | **Classification** |
| Derivatives designated as hedges: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | $— | $(3) | $— | $2 | $— | $— | Sales and other operating revenues |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities | (12) | (17) | 2 | 73 |  |  | Cost of sales |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | (392) | 120 | 35 | (27) | 25 | 35 | Interest expense |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rates |  | 11 | 2 | 2 | 20 | (61) | Interest expense |
| Derivatives not designated as hedges: | Derivatives not designated as hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities |  |  |  |  |  | (1) | Sales and other operating revenues |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities |  |  |  |  | (36) | 3 | Cost of sales |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commodities |  |  |  |  | 8 | 6 | (Loss) income from discontinued operations, net of tax |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency |  |  |  |  | (81) | 24 | Other income, net |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $(404) | $111 | $39 | $50 | $(64) | $6 |  |

---

As of June 30, 2025, on a pre-tax basis, $5 million is scheduled to be reclassified from AOCI as an increase to Interest expense over the next twelve months.

*Other Financial Instruments:*

*Cash and Cash Equivalents*—As of June 30, 2025 and December 31, 2024, we had marketable securities classified as Cash and cash equivalents of $820 million and $2,610 million, respectively.

**10.&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes**

For interim tax reporting, we estimate an annual effective tax rate which is applied to the year-to-date ordinary income. Tax effects of significant, unusual, or infrequently occurring items are excluded from the estimated annual effective tax rate calculation and recognized in the interim period in which they occur. Our effective income tax rate fluctuates based on, among other factors, changes in pre-tax income in countries with varying statutory tax rates, changes in valuation allowances, changes in foreign exchange gains or losses, the amount of exempt income, changes in unrecognized tax benefits associated with uncertain tax positions and changes in tax laws.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

Our exempt income primarily includes interest income, export incentives, and equity earnings of joint ventures. Interest income earned by certain of our subsidiaries through intercompany financings is taxed at rates substantially lower than the U.S. statutory rate. Export incentives relate to tax benefits derived from elections and structures available for U.S. exports. Equity earnings attributable to the earnings of our joint ventures, when paid through dividends to certain European subsidiaries, are exempt from all or portions of normal statutory income tax rates. We currently anticipate the favorable treatment for interest income, dividends, and export incentives to continue in the current year based on current law. The United Kingdom, as well as certain other jurisdictions in which we operate, enacted legislation implementing the Organization for Economic Cooperation and Development's Pillar Two Model Rules effective as of January 1, 2024. This legislation did not have a material impact on the Consolidated Financial Statements, however, we continue to assess and monitor legislative changes.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted into law. OBBBA includes tax reform extending and modifying certain key Tax Cuts & Jobs Act provisions such as accelerated tax deductions for qualified property and domestic research expenditures, and modifications to the limitations on deductions for interest expense. The provisions of the OBBBA have different effective dates where some are effective in 2025 and others not until 2026. This legislation is not expected to have a material impact on the Consolidated Financial Statements; however, we continue to assess the impact.

Our effective income tax rate for the second quarter of 2025 was 30.8% compared to 21.1% for the second quarter of 2024. The higher effective tax rate for the second quarter of 2025 was primarily due to the discrete tax recognition of foreign exchange gains and losses with lower pre-tax earnings that increased our effective income tax rate by 26.9 percentage points. This increase to the effective tax rate was partially offset by the increased relative impact of our tax rate drivers, primarily exempt income and fluctuations in return to accruals, due to lower earnings that decreased our effective income tax rate by 15.3 percentage points.

Our effective income tax rate for the first six months of 2025 was 37.1% compared to 20.8% for the first six months of 2024. The higher effective tax rate for the first six months of 2025 was primarily due to the discrete tax recognition of foreign exchange gains and losses with lower pre-tax earnings that increased our effective tax rate by 32.2 percentage points. This increase to the effective tax rate was partially offset by the increased relative impact of our tax rate drivers, primarily exempt income, due to decreased earnings that decreased our effective income tax rate by 11.9 percentage points.

**11.&nbsp;&nbsp;&nbsp;&nbsp;Commitments and Contingencies**

*Commitments*—We have various purchase commitments for materials, supplies and services incidental to the ordinary conduct of business, generally for quantities required for our businesses and at prevailing market prices. These commitments are designed to ensure sources of supply and are not expected to be in excess of normal requirements. Additionally, we have capital expenditure commitments, which we incur in our normal course of business.

*Financial Assurance Instruments*—We have obtained letters of credit, performance and surety bonds and have issued financial and performance guarantees to support trade payables, potential liabilities and other obligations. Considering the frequency of claims made against the financial instruments we use to support our obligations, and the magnitude of those financial instruments in light of our current financial position, management does not expect that any claims against or draws on these instruments would have a material adverse effect on the Consolidated Financial Statements. We have not experienced any unmanageable difficulties in obtaining the required financial assurance instruments for our current operations.

*Environmental Remediation*—Accrued liabilities for future environmental remediation costs at current and former plant sites and other remediation sites totaled $101 million and $140 million as of June 30, 2025 and December 31, 2024, respectively. As of June 30, 2025, the accrued liabilities for individual sites range from less than $1 million to $41 million. The remediation expenditures are expected to occur over a number of years and are not concentrated in any single year. In our opinion, it is reasonably possible that losses in excess of the liabilities recorded may have been incurred. However, we cannot estimate any amount or range of such possible additional losses. New information about sites, new technology or future developments, such as involvement in investigations by regulatory agencies, could require us to reassess our potential exposure related to environmental matters.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

*Indemnification*—We are parties to various indemnification arrangements, including arrangements entered into in connection with acquisitions, divestitures and the formation and dissolution of joint ventures. Pursuant to these arrangements, we provide indemnification to and/or receive indemnification from other parties in connection with liabilities that may arise in connection with the transactions and in connection with activities prior to completion of the transactions. These indemnification arrangements typically include provisions pertaining to third-party claims relating to environmental and tax matters and various types of litigation. As of June 30, 2025, we had not accrued any significant amounts for our indemnification obligations, and we are not aware of other circumstances that would likely lead to significant future indemnification obligations. We cannot determine with certainty the potential amount of future payments under the indemnification arrangements until events arise that would trigger a liability under the arrangements.

As part of our technology licensing contracts, we give indemnifications to our licensees for liabilities arising from possible patent infringement claims with respect to certain proprietary licensed technologies. Such indemnifications have a stated maximum amount and generally cover a period of 5 to 10 years.

*Legal Proceedings—*We are subject to various lawsuits and claims, including but not limited to, matters involving contract disputes, tort claims, and regulatory disputes alleging environmental damages, personal injury and/or property damage, some of which are covered by insurance. We vigorously defend ourselves and prosecute these matters as appropriate.

Our legal organization applies its knowledge, experience and professional judgment to the specific characteristics of our cases, employing a litigation management process to manage and monitor legal proceedings in which we are a party. Our process facilitates the early evaluation and quantification of potential exposures in individual cases. This process also enables us to track those cases that have been scheduled for trial, mediation or other resolution. We regularly assess the adequacy of legal accruals based on our professional judgment, experience and the information available regarding our cases.

Based on consideration of all relevant facts and circumstances, we do not believe the ultimate outcome of any currently pending lawsuit or claim against us will have a material adverse effect upon our operations, financial condition or Consolidated Financial Statements.

**12.&nbsp;&nbsp;&nbsp;&nbsp;Shareholders' Equity and Redeemable Non-controlling Interests**

***Shareholders' Equity***

*Dividend Distributions*—The following table summarizes the quarterly dividends paid in the period presented:

---

| | | | |
|:---|:---|:---|:---|
| **<u>Millions of dollars, except per share amounts</u>** | **Dividend Per<br>Ordinary Share** | **Aggregate<br>Dividends Paid** | **Date of Record** |
| March 2025 | $1.34 | $433 | March 10, 2025 |
| June 2025 | 1.37 | 445 | June 2, 2025 |
|  | $2.71 | $878 |  |

---

*Share Repurchase Authorization*—In May 2025, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares, through November 23, 2026 ("2025 Share Repurchase Authorization"), which superseded any prior repurchase authorizations. The timing and amount of these repurchases, which are determined based on our evaluation of market conditions and other factors, may be executed from time to time through open market or privately negotiated transactions. The repurchased shares, which are recorded at cost, are classified as Treasury stock and may be retired or used for general corporate purposes, including for various employee benefit and compensation plans.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

The following table summarizes our share repurchase activity for the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| **<u>Millions of dollars, except shares and per share amounts</u>** | **Shares<br>Repurchased** | **Average<br>Purchase<br>Price Per Share** | **Total Purchase Price, Including<br>Commissions and Fees** |
| For the six months ended June 30, 2025: |  |  |  |
| 2024 Share Repurchase Authorization | 3037987 | $66.01 | $201 |
| For the six months ended June 30, 2024: |  |  |  |
| 2024 Share Repurchase Authorization | 784505 | $95.62 | $75 |

---

Total cash paid for share repurchases for the six months ended June 30, 2025 and 2024 was $201 million and $75 million, respectively.

*Ordinary Shares*—The changes in the outstanding amounts of ordinary shares are as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| | **2025** | **2024** |
| Ordinary shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning balance | 323889832 | 324483402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | 491005 | 1203741 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee stock purchase plan | 284760 | 176046 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of ordinary shares | (3037987) | (784505) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 321627610 | 325078684 |

---

*Treasury Shares—*The changes in the amounts of treasury shares held by the Company are as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| | **2025** | **2024** |
| Ordinary shares held as treasury shares: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning balance | 16532666 | 15939096 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | (491005) | (1203741) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee stock purchase plan | (284760) | (176046) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of ordinary shares | 3037987 | 784505 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ending balance | 18794888 | 15343814 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

*Accumulated Other Comprehensive Loss*—The components of, and after-tax changes in, Accumulated other comprehensive loss as of and for the six months ended June 30, 2025 and 2024 are presented in the following tables.

Foreign Currency Translation Adjustments below include currency translation adjustments as well as gains (losses) on net investment hedges; the associated tax benefits or expenses are calculated separately for each component.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Millions of dollars</u>** | **Financial<br>Derivatives** | **Defined Benefit<br>Pension and Other<br>Postretirement<br>Benefit Plans** | **Foreign<br>Currency<br>Translation<br>Adjustments** | **Total** |
| December 31, 2024 | $(111) | $(281) | $(1140) | $(1532) |
| Other comprehensive income (loss) before reclassifications | (47) | (3) | 96 | 46 |
| Tax benefit before reclassifications | 12 | 1 | 93 | 106 |
| Amounts reclassified from accumulated other comprehensive loss | 39 | (1) |  | 38 |
| Tax expense | (10) | (1) |  | (11) |
| Net other comprehensive income (loss) | (6) | (4) | 189 | 179 |
| Balance – June 30, 2025 | $(117) | $(285) | $(951) | $(1353) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Millions of dollars</u>** | **Financial<br>Derivatives** | **Defined Benefit<br>Pension and Other<br>Postretirement<br>Benefit Plans** | **Foreign<br>Currency<br>Translation<br>Adjustments** | **Total** |
| Balance – December 31, 2023 | $(226) | $(279) | $(971) | $(1476) |
| Other comprehensive income (loss) before reclassifications | 17 |  | (79) | (62) |
| Tax expense before reclassifications | (5) |  | (25) | (30) |
| Amounts reclassified from accumulated other comprehensive loss | 50 | 8 |  | 58 |
| Tax expense | (12) | (1) |  | (13) |
| Net other comprehensive income (loss) | 50 | 7 | (104) | (47) |
| Balance – June 30, 2024 | $(176) | $(272) | $(1075) | $(1523) |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

The amounts reclassified out of each component of Accumulated other comprehensive loss are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Affected Line Item on<br>the Consolidated<br>Statements of Income** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** | **Affected Line Item on<br>the Consolidated<br>Statements of Income** |
| Reclassification adjustments for: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Financial derivatives: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities | $— | $1 | $— | $2 | Sales and other operating revenues |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodities | 4 | 35 | 2 | 73 | Cost of sales |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency | 24 | 1 | 35 | (27) | Interest expense |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rates | 1 | 1 | 2 | 2 | Interest expense |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | (7) | (11) | (10) | (12) | Provision for income taxes |
| &nbsp;&nbsp;&nbsp;&nbsp;Financial derivatives, net of tax | 22 | 27 | 29 | 38 |  |
| &nbsp;&nbsp;&nbsp;Amortization of defined pension items: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Actuarial loss | 3 | 4 | 6 | 7 | Other income, net |
| &nbsp;&nbsp;&nbsp;&nbsp;Prior service cost | 1 |  | 2 | 1 | Other income, net |
| &nbsp;&nbsp;&nbsp;&nbsp;Curtailment gain |  |  | (9) |  | Income from discontinued operations, net of tax |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | (2) |  | (1) | (1) | Provision for income taxes |
| &nbsp;&nbsp;&nbsp;&nbsp;Defined pension items, net of tax | 2 | 4 | (2) | 7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total reclassifications, before tax | 33 | 42 | 38 | 58 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | (9) | (11) | (11) | (13) | Provision for income taxes |
| &nbsp;&nbsp;&nbsp;&nbsp;Total reclassifications, after tax | $24 | $31 | $27 | $45 | Amount included in net income |

---

***Redeemable Non-controlling Interests***

Our redeemable non-controlling interests relate to shares of cumulative perpetual special stock ("redeemable non-controlling interest stock") issued by a consolidated subsidiary. As of June 30, 2025 and December 31, 2024, we had 113,053 shares of redeemable non-controlling interest stock outstanding. These shares may be redeemed at any time at the discretion of the holders.

In January and May 2025, we paid cash dividends of $15.00 per share to our redeemable non-controlling interest shareholders of record as of January 15, 2025 and April 15, 2025. These dividends totaled $3 million for each of the six month periods ended June 30, 2025 and 2024.

**13.&nbsp;&nbsp;&nbsp;&nbsp;Per Share Data**

Basic earnings per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share includes the effect of certain stock options and other equity-based compensation awards. Our unvested restricted stock units contain non-forfeitable rights to dividend equivalents and are considered participating securities. We compute basic and diluted earnings per share under the two-class method.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

Earnings per share data is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Three Months Ended June 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| **<u>Millions of dollars</u>** | **Continuing<br>Operations** | **Discontinued<br>Operations** | **Continuing<br>Operations** | **Discontinued<br>Operations** |
| Net income (loss) | $155 | $(40) | $946 | $(22) |
| Dividends on redeemable non-controlling interests | (1) |  | (1) |  |
| Net income attributable to participating securities | (3) |  | (5) |  |
| Net income (loss) attributable to ordinary shareholders – basic and diluted | $151 | $(40) | $940 | $(22) |
| **<u>Millions of shares, except per share amounts</u>** |  |  |  |  |
| Basic weighted average common stock outstanding | 322 | 322 | 325 | 325 |
| Effect of dilutive securities |  |  | 1 | 1 |
| Diluted weighted average common stock outstanding | 322 | 322 | 326 | 326 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.47 | $(0.13) | $2.89 | $(0.07) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.47 | $(0.13) | $2.88 | $(0.06) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2025** | **2024** | **2024** |
| **<u>Millions of dollars</u>** | **Continuing<br>Operations** | **Discontinued<br>Operations** | **Continuing<br>Operations** | **Discontinued<br>Operations** |
| Net income | $178 | $114 | $1379 | $18 |
| Dividends on redeemable non-controlling interests | (3) |  | (3) |  |
| Net income attributable to participating securities | (5) |  | (6) |  |
| Net income attributable to ordinary shareholders – basic and diluted | $170 | $114 | $1370 | $18 |
| **<u>Millions of shares, except per share amounts</u>** |  |  |  |  |
| Basic weighted average common stock outstanding | 323 | 323 | 325 | 325 |
| Effect of dilutive securities |  |  | 1 | 1 |
| Diluted weighted average common stock outstanding | 323 | 323 | 326 | 326 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.53 | $0.35 | $4.21 | $0.05 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.53 | $0.35 | $4.20 | $0.05 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

**14. Segment and Related Information**

Our operations are managed by senior executives who report to our Chief Executive Officer, the chief operating decision maker. Discrete financial information is available for each of the segments. The Chief Executive Officer uses EBITDA as the primary measure for reviewing the profitability of our segments and allocating resources to the segments. We define EBITDA as net income before interest, income taxes, and depreciation and amortization. Our chief operating decision maker does not receive information about total assets by reportable segment.

The activities of each of our segments from which they earn revenues and incur expenses are described below:

&nbsp;&nbsp;&nbsp;&nbsp;***•*** *Olefins and Polyolefins-Americas ("O&P-Americas")*. Our O&P-Americas segment produces and markets olefins and co-products, polyethylene and polypropylene.

&nbsp;&nbsp;&nbsp;&nbsp;***•*** *Olefins and Polyolefins-Europe, Asia, International ("O&P-EAI")*. Our O&P-EAI segment produces and markets olefins and co-products, polyethylene and polypropylene.

&nbsp;&nbsp;&nbsp;&nbsp;• *Intermediates and Derivatives* (*"I&D"*). Our I&D segment produces and markets propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals such as styrene monomer and acetyls.

&nbsp;&nbsp;&nbsp;&nbsp;***•*** *Advanced Polymer Solutions ("APS").* Our APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors and powders.

&nbsp;&nbsp;&nbsp;&nbsp;• *Technology*. Our Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts.

"Other" includes intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other postretirement benefit costs other than service costs. Sales between segments are made at prices approximating prevailing market prices.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

Summarized financial information concerning reportable segments is shown in the following tables for the periods presented:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** |
| **<u>Millions of dollars</u>** | **O&P–<br>Americas** | **O&P–<br>EAI** | **I&D** | **APS** | **Technology** | **Other** | **Total** |
| Sales and other operating revenues: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customers | $1851 | $2537 | $2244 | $913 | $113 | $— | $7658 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment | 526 | 167 | 31 | 4 | 24 | (752) |  |
|  | 2377 | 2704 | 2275 | 917 | 137 | (752) | 7658 |
| Less: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 2108 | 2575 | 2048 | 807 | 82 | (749) | 6871 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairments |  | 32 |  |  |  |  | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income from equity investments | (4) | (3) |  |  |  |  | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other items | 124 | 136 | 40 | 98 | 33 | 10 | 441 |
| Add: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 164 | 38 | 99 | 20 | 11 |  | 332 |
| EBITDA | $313 | $2 | $286 | $32 | $33 | $(13) | $653 |
| Capital expenditures | $305 | $115 | $73 | $19 | $27 | $— | $539 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** |
| **<u>Millions of dollars</u>** | **O&P–<br>Americas** | **O&P–<br>EAI** | **I&D** | **APS** | **Technology** | **Other** | **Total** |
| Sales and other operating revenues: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customers | $2188 | $2659 | $2751 | $943 | $137 | $— | $8678 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment | 738 | 183 | 44 | 5 | 22 | (992) |  |
|  | 2926 | 2842 | 2795 | 948 | 159 | (992) | 8678 |
| Less: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 2297 | 2693 | 2344 | 844 | 57 | (991) | 7244 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss from equity investments | 1 | 16 | 2 |  |  |  | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business |  |  | (293) |  |  |  | (293) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other items | 110 | 117 | 51 | 86 | 28 | 6 | 398 |
| Add: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 152 | 54 | 103 | 22 | 10 |  | 341 |
| EBITDA | $670 | $70 | $794 | $40 | $84 | $(7) | $1651 |
| Capital expenditures | $174 | $107 | $150 | $25 | $20 | $2 | $478 |

---

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** |
| **<u>Millions of dollars</u>** | **O&P-<br>Americas** | **O&P-<br>EAI** | **I&D** | **APS** | **Technology** | **Other** | **Total** |
| Sales and other operating revenues: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customers | $3808 | $4972 | $4526 | $1817 | $212 | $— | $15335 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment | 1050 | 332 | 47 | 8 | 45 | (1482) |  |
|  | 4858 | 5304 | 4573 | 1825 | 257 | (1482) | 15335 |
| Less: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 4381 | 5085 | 4281 | 1607 | 126 | (1481) | 13999 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairments |  | 32 |  |  |  |  | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Income) loss from equity investments | (11) | 3 |  |  |  |  | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other items | 243 | 242 | 110 | 180 | 67 | 13 | 855 |
| Add: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 319 | 77 | 198 | 40 | 21 |  | 655 |
| EBITDA | $564 | $19 | $380 | $78 | $85 | $(14) | $1112 |
| Capital expenditures | $521 | $239 | $164 | $49 | $49 | $— | $1022 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** |
| **<u>Millions of dollars</u>** | **O&P–<br>Americas** | **O&P–<br>EAI** | **I&D** | **APS** | **Technology** | **Other** | **Total** |
| Sales and other operating revenues: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customers | $4275 | $5221 | $5278 | $1903 | $305 | $— | $16982 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intersegment | 1522 | 366 | 103 | 10 | 46 | (2047) |  |
|  | 5797 | 5587 | 5381 | 1913 | 351 | (2047) | 16982 |
| Less: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 4697 | 5336 | 4644 | 1705 | 109 | (2047) | 14444 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Income) loss from equity investments | (8) | 48 | 6 |  |  |  | 46 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business |  |  | (293) |  |  |  | (293) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other items | 220 | 225 | 121 | 175 | 61 | 15 | 817 |
| Add: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 303 | 106 | 203 | 42 | 21 |  | 675 |
| EBITDA | $1191 | $84 | $1106 | $75 | $202 | $(15) | $2643 |
| Capital expenditures | $355 | $194 | $292 | $48 | $44 | $3 | $936 |

---

Other items include Selling, general and administrative ("SG&A") expenses, Research and development expenses, and Other income, net.

------

<u>[**Table of Contents**](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**LYONDELLBASELL INDUSTRIES N.V.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS-(Continued)**

A reconciliation of EBITDA to Income from continuing operations before income taxes is shown in the following table for each of the periods presented. Indirect SG&A expense reallocation to continuing operations represents corporate SG&A expenses that were previously allocated to the refining segment:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** | **2025** | **2024** |
| EBITDA: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total segment EBITDA | $666 | $1658 | $1126 | $2658 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other EBITDA | (13) | (7) | (14) | (15) |
| Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | (332) | (341) | (655) | (675) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (118) | (120) | (225) | (247) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indirect SG&A expense reallocation to continuing operations |  | (28) |  | (57) |
| Add: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income | 21 | 37 | 51 | 78 |
| Income from continuing operations before income taxes | $224 | $1199 | $283 | $1742 |

---

*Closure of European PO Joint Venture—*In March 2025, we announced our plans to permanently close the Propylene Oxide Styrene Monomer (POSM) production unit at the Maasvlakte site in the Netherlands. The Maasvlakte site is a joint venture between us and Covestro (our "European PO Joint Venture"). The joint venture was formed solely for the benefit of the partners and does not manufacture for any other parties. We report the cost of our product off-take as Inventory and the equity loss as Cost of sales in our Consolidated Financial Statements.

As of December 31, 2024, the book value of the European PO Joint Venture was immaterial largely due to asset impairments recognized during 2023. We will carry out a process to safely shut down and prepare for the demolition of the asset. We estimate our portion of the total shutdown costs will be approximately $215 million and will be incurred through 2027. During the first quarter of 2025, we incurred $117 million of shutdown costs.

*Disposition of Ethylene Oxide & Derivatives ("EO&D") Business*—In May 2024, we sold our U.S. Gulf Coast-based EO&D business along with the production facilities located in Bayport, TX. The EO&D business was included in our I&D segment. In connection with the sale, we received cash proceeds of $700 million and recognized a pre-tax gain of $293 million in the first six months of 2024.

*Acquisition of Joint Venture*—In May 2024, we acquired a 35% interest in Saudi Arabia-based National Petrochemical Industrial Company ("NATPET") from Alujain Corporation for approximately $500 million. The joint venture is enabled by our Spheripol polypropylene ("PP") technology and positions us to expand our core PP business by gaining access to advantaged feedstocks. The joint venture has the capacity to produce 0.4 million tons of PP per year. We market the majority of the off-take through our global sales team. The joint venture is included in our O&P-EAI segment and accounted for using the equity method of accounting.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

**GENERAL**

This discussion should be read in conjunction with the information contained in the Consolidated Financial Statements, and the accompanying notes elsewhere in this report. Unless otherwise indicated, the "Company," "we," "us," "our" or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries ("LyondellBasell N.V.").

In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation. The related operating results of our refining business are reported as discontinued operations for all periods presented.

**OVERVIEW**

Results from continuing operations for the second quarter of 2025 increased compared to the first quarter of 2025. In our Olefins and Polyolefins-Americas ("O&P-Americas") segment, the completion of a turnaround at our Channelview complex resulted in higher operating rates that supported a sequential improvement in integrated polyethylene volumes and margins. In our Olefins and Polyolefins-Europe, Asia, International ("O&P-EAI") segment, lower feedstock costs helped improve integrated polyethylene margins while polyolefin volumes benefited from increased seasonal demand. These improvements were offset by the recognition of a non-cash impairment related to European assets classified as held for sale within our O&P-EAI segment. In our Intermediates and Derivatives ("I&D") segment, intermediate chemical margins improved due to lower benzene costs and price support from second quarter industry outages. Oxyfuels and related products margins fell as lower crude oil prices limited the typical seasonal uplift from the summer driving season. Results for our I&D segment were further improved by the absence of shutdown costs related to our Propylene Oxide Styrene Monomer (POSM) production unit at the Maasvlakte site in the Netherlands (the "European PO Joint Venture") recognized in the first quarter of 2025. During the second quarter, global markets began to adapt to trade volatility, contributing to a more stable operating environment across several product chains.

Results from continuing operations for the first six months of 2025 decreased compared to the first six months of 2024. In our I&D segment, oxyfuels and related products margins declined due to lower crude oil prices. Results for our I&D segment were further impacted by the recognition of shutdown costs mentioned above and a gain on sale of our U.S. Gulf Coast-based Ethylene Oxide & Derivatives ("EO&D") business recognized during the second quarter of 2024. In our O&P-Americas segment, margins decreased across most businesses as feedstock and energy costs increased compared to the prior year. In our Technology segment, licensing results decreased as the planned pace of global polyolefin capacity additions moderate.

In June 2025, we entered into an agreement for the sale of select olefins & polyolefins assets and the associated business in Europe. The sites to be sold have been part of the previously announced European strategic assessment and are located in Berre l'Etang (France), Münchsmünster (Germany), Carrington (United Kingdom), and Tarragona (Spain). In connection with the sale, we expect to recognize a loss on sale of approximately $700 million to $900 million upon closing.

During the first six months of 2025 we used $228 million of cash from operating activities primarily reflecting earnings adjusted for non-cash items, timing of payment of Accounts payable and tax payments, including U.S. Federal corporate income tax payments deferred from 2024 into 2025 under Hurricane Beryl disaster relief. In connection with our overall capital allocation strategy, we invested $1,022 million in capital expenditures and returned $1,079 million to shareholders through dividend payments and share repurchases.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

Results of operations for the periods discussed are presented in the table below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| Sales and other operating revenues | $7658 | $7677 | $15335 | $16982 |
| Cost of sales | 6871 | 7128 | 13999 | 14444 |
| Impairments | 32 |  | 32 |  |
| Selling, general and administrative expenses | 435 | 401 | 836 | 823 |
| Research and development expenses | 35 | 34 | 69 | 65 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income | 285 | 114 | 399 | 1650 |
| Interest expense | (118) | (107) | (225) | (247) |
| Interest income | 21 | 30 | 51 | 78 |
| Gain on sale of business |  |  |  | 293 |
| Other income, net | 29 | 21 | 50 | 14 |
| Income (loss) from equity investments | 7 | 1 | 8 | (46) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before income taxes | 224 | 59 | 283 | 1742 |
| Provision for income taxes | 69 | 36 | 105 | 363 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations | 155 | 23 | 178 | 1379 |
| (Loss) income from discontinued operations, net of tax | (40) | 154 | 114 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 115 | 177 | 292 | 1397 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss), net of tax – |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial derivatives | (35) | 29 | (6) | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined benefit pension and other postretirement benefit plans | 2 | (6) | (4) | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translations | 127 | 62 | 189 | (104) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss), net of tax | 94 | 85 | 179 | (47) |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income | $209 | $262 | $471 | $1350 |

---

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**RESULTS OF OPERATIONS**

**Revenues**—Revenues remained relatively unchanged in the second quarter of 2025 compared to the first quarter of 2025. Lower average sales prices for many of our products resulted in a 5% decrease in revenues. Favorable foreign exchange impact resulted in a 4% increase in revenues. Higher sales volumes resulted in a 1% increase in revenue.

Revenues decreased by $1,647 million or 10% in the first six months of 2025 compared to the first six months of 2024. Lower sales volumes driven by lower demand led to an 6% decrease in revenues. Lower average sales prices for many of our products resulted in a 5% decrease in revenues. Favorable foreign exchange impact led to a 1% increase in revenues.

**Cost of Sales**—Cost of sales decreased by $257 million, or 4%, in the second quarter of 2025 compared to the first quarter of 2025 and by $445 million or 3% in the first six months of 2025 compared to the first six months of 2024 primarily due to lower feedstock and energy costs. Additionally, during the first quarter of 2025 we recognized $117 million in shutdown costs related to our plans to permanently close the European PO Joint Venture.

**Impairments**—During the second quarter of 2025, we recognized a non-cash impairment charge of $32 million related to property, plant and equipment associated with the European assets classified as held for sale within our O&P EAI segment.

**Operating Income**—Operating income increased by $171 million, or 150%, in the second quarter of 2025 compared to the first quarter of 2025. Operating income in our I&D and O&P-Americas segments increased by $160 million and $57 million, respectively. These increases were partially offset by decreases in our Technology, O&P-EAI, and APS segments of $20 million, $17 million, and $7 million, respectively.

Operating income decreased by $1,251 million, or 76%, in the first six months of 2025 compared to the first six months of 2024. Operating income in our O&P-Americas, I&D, Technology, O&P-EAI and APS segments decreased by $648 million, $462 million, $117 million, $82 million and $1 million, respectively.

Results for each of our business segments are discussed further in the "Segment Analysis" section below.

**Gain on Sale of Business**—In the second quarter of 2024, we completed the sale of our EO&D business and associated production facilities located in Bayport, Texas and recognized a pre-tax gain of $293 million.

**Income (Loss) from Equity Investments**—Income from equity investments increased by $6 million, in the second quarter of 2025 compared to the first quarter of 2025 primarily as a result of improved results following a turnaround in the first quarter of 2025 at a Saudi Arabian joint venture in our O&P EAI segment. Income from equity investments increased by $54 million or 117% in the first six months of 2025 compared to the first six months of 2024 as the first six months of 2024 included equity losses recognized by a Chinese joint venture in our O&P-EAI segment. Our Chinese joint venture was subsequently fully impaired during the fourth quarter of 2024.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Income Taxes**—Our effective income tax rate for the second quarter of 2025 was 30.8% compared to 61.0% for the first quarter of 2025. The lower effective tax rate for the second quarter of 2025 was due to the relative impact of our tax rate drivers, primarily exempt income, foreign exchange gains and losses, and fluctuations in return to accruals, due to higher earnings that decreased our effective income tax rate by 43.5 percentage points. This decrease was partially offset by an increase in the discrete tax recognition of foreign exchange gains and losses by 15.2 percentage points.

Our effective income tax rate for the first six months of 2025 was 37.1% compared to 20.8% for the first six months of 2024. The higher effective tax rate for the first six months of 2025 was primarily due to the discrete tax recognition of foreign exchange gains and losses with lower pre-tax earnings that increased our effective tax rate by 32.2 percentage points. This increase to the effective tax rate was partially offset by the increased relative impact of our tax rate drivers, primarily exempt income, due to decreased earnings that decreased our effective income tax rate by 11.9 percentage points.

**Income (Loss) from Discontinued Operations, Net of Tax**—Income from discontinued operations decreased by $194 million in the second quarter of 2025 compared to the first quarter of 2025, and increased $96 million in the first six months of 2025 compared to the first six months of 2024. These changes were primarily the result of the recognition a last-in, first-out ("LIFO") benefit of $196 million for the liquidation of low cost inventory in the first quarter of 2025. The remainder of the change was primarily driven by the cessation of business operations at our Houston refinery in February of 2025.

**Comprehensive Income**—Comprehensive income decreased by $53 million in the second quarter of 2025 compared to the first quarter of 2025, primarily due to the decrease in Net income and decreases in financial derivatives partially offset by the net favorable impacts of unrealized changes in foreign currency translation adjustments. Comprehensive income decreased by $879 million in the first six months of 2025 compared to the first six months of 2024, primarily due to the decrease in Net income partially offset by the net favorable impacts of unrealized changes in foreign currency translation adjustments. The components of Other comprehensive income (loss) are discussed below.

Financial derivatives designated as cash flow hedges, primarily our commodity swaps, led to a decrease in Comprehensive income of $64 million and $56 million in the second quarter of 2025 compared to the first quarter of 2025 and in the first six months of 2025 compared to the first six months of 2024, respectively, reflecting commodity price volatility.

Foreign currency translations increased Comprehensive income by $65 million and $293 million in the second quarter of 2025 compared to the first quarter of 2025 and in the first six months of 2025 compared to the first six months of 2024, respectively, primarily due to the weakening of the U.S. dollar relative to the euro, partially offset by the effective portion of our net investment hedges.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Segment Analysis**

We use net income before interest, income taxes, and depreciation and amortization ("EBITDA") as our measure of profitability for segment reporting purposes. This measure of segment operating results is used by our chief operating decision maker to assess the performance of and allocate resources to our operating segments. Intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other postretirement benefits other than service costs are included in "Other". See the table below for a reconciliation of EBITDA to its nearest generally accepted accounting principles ("GAAP") measure.

The following table presents the reconciliation of Net income to EBITDA for each of the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| **Net income** | $115 | $177 | $292 | $1397 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 62 | 78 | 140 | 371 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 332 | 323 | 655 | 752 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 97 | 77 | 174 | 169 |
| **EBITDA** | $606 | $655 | $1261 | $2689 |

---

Our continuing operations are managed through five reportable segments: O&P-Americas, O&P-EAI, I&D, APS, and Technology. Revenues and other information by segment for the periods presented are reflected in the tables below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| **Sales and other operating revenues:** |  |  |  |  |
| O&P-Americas segment | $2377 | $2481 | $4858 | $5797 |
| O&P-EAI segment | 2704 | 2600 | 5304 | 5587 |
| I&D segment | 2275 | 2298 | 4573 | 5381 |
| APS segment | 917 | 908 | 1825 | 1913 |
| Technology segment | 137 | 120 | 257 | 351 |
| Other, including intersegment eliminations | (752) | (730) | (1482) | (2047) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $7658 | $7677 | $15335 | $16982 |
| **Operating income (loss):** |  |  |  |  |
| O&P-Americas segment | $142 | $85 | $227 | $875 |
| O&P-EAI segment | (40) | (23) | (63) | 19 |
| I&D segment | 151 | (9) | 142 | 604 |
| APS segment | 10 | 17 | 27 | 28 |
| Technology segment | 22 | 42 | 64 | 181 |
| Other, including intersegment eliminations |  | 2 | 2 | (57) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $285 | $114 | $399 | $1650 |

---

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| **Depreciation and amortization:** |  |  |  |  |
| O&P-Americas segment | $164 | $155 | $319 | $303 |
| O&P-EAI segment | 38 | 39 | 77 | 106 |
| I&D segment | 99 | 99 | 198 | 203 |
| APS segment | 20 | 20 | 40 | 42 |
| Technology segment | 11 | 10 | 21 | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $332 | $323 | $655 | $675 |
| **Income (loss) from equity investments:** |  |  |  |  |
| O&P-Americas segment | $4 | $7 | $11 | $8 |
| O&P-EAI segment | 3 | (6) | (3) | (48) |
| I&D segment |  |  |  | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $7 | $1 | $8 | $(46) |
| **Gain on sale of business:** |  |  |  |  |
| I&D segment | $— | $— | $— | $293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $— | $— | $293 |
| **Other income, net:** |  |  |  |  |
| O&P-Americas segment | $3 | $4 | $7 | $5 |
| O&P-EAI segment | 1 | 7 | 8 | 7 |
| I&D segment | 36 | 4 | 40 | 12 |
| APS segment | 2 | 9 | 11 | 5 |
| Other, including intersegment eliminations | (13) | (3) | (16) | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $29 | $21 | $50 | $14 |
| **EBITDA:** |  |  |  |  |
| O&P-Americas segment | $313 | $251 | $564 | $1191 |
| O&P-EAI segment | 2 | 17 | 19 | 84 |
| I&D segment | 286 | 94 | 380 | 1106 |
| APS segment | 32 | 46 | 78 | 75 |
| Technology segment | 33 | 52 | 85 | 202 |
| Discontinued operations | (47) | 196 | 149 | 103 |
| Other, including intersegment eliminations | (13) | (1) | (14) | (72) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $606 | $655 | $1261 | $2689 |

---

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

***Olefins and Polyolefins-Americas Segment***

**Overview**—EBITDA increased in the second quarter of 2025 compared to the first quarter of 2025 primarily due to higher polyethylene margins. EBITDA decreased in the first six months of 2025 relative to the first six months of 2024 as margins decreased for most businesses.

*Ethylene Raw Materials—*Ethylene and its co-products are produced from two major raw material groups:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*•* natural gas liquids ("NGLs"), principally ethane and propane, the prices of which are generally affected by natural gas prices; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• crude oil-based liquids ("liquids" or "heavy liquids"), including naphtha, condensates and gas oils, the prices of which are generally related to crude oil prices.

We have flexibility to vary the raw material mix and process conditions in our U.S. olefins plants in order to maximize profitability as market prices fluctuate for both feedstocks and products. Although prices of crude-based liquids and natural gas liquids are generally related to crude oil and natural gas prices, during specific periods the relationships among these materials and benchmarks may vary significantly. In the second and first quarter of 2025, and the first six months of 2025 and 2024, approximately 75% to 80% of the raw materials used in our North American crackers was ethane.

The following table sets forth selected financial information for the O&P-Americas segment including Income from equity investments, which is a component of EBITDA:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| Sales and other operating revenues | $2377 | $2481 | $4858 | $5797 |
| Income from equity investments | 4 | 7 | 11 | 8 |
| EBITDA | 313 | 251 | 564 | 1191 |

---

**Revenue**—Revenues for our O&P-Americas segment decreased by $104 million, or 4% in the second quarter of 2025 compared to the first quarter of 2025 and by $939 million, or 16%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—The revenue decrease was due to lower volumes sold during the second quarter of 2025 relative to the first quarter of 2025.

*First six months of 2025 versus first six months of 2024*—Volumes driven by planned and unplanned outages resulted in a 12% decrease in revenue. Lower average sales prices driven by lower oil price environment resulted in a 4% decrease in revenue.

**EBITDA**—EBITDA increased by $62 million, or 25%, in the second quarter of 2025 compared to the first quarter of 2025 and decreased by $627 million, or 53%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—Higher polyethylene results led to a 33% increase in EBITDA driven by improved margins primarily from lower ethylene costs. Lower olefins results led to a 7% decrease in EBITDA driven primarily by lower margins due to lower ethylene sales price partially offset by lower feedstock and energy prices.

*First six months of 2025 versus first six months of 2024*—Lower olefins results led to a 32% decrease in EBITDA driven by lower ethylene margins from a decrease in co-product contribution combined with higher energy costs. Lower polyethylene results led to a 19% decrease in EBITDA primarily driven by lower product margins attributed to unfavorable macroeconomic conditions.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

***Olefins and Polyolefins-Europe, Asia, International Segment***

**Overview**—EBITDA decreased in the second quarter of 2025 relative to the first quarter of 2025 and in the first six months of 2025 relative to the first six months of 2024 primarily due to the recognition of a $32 million impairment charge recognized in the second quarter of 2025 related to assets held for sale.

Higher olefins margins in the second quarter of 2025 compared to the first quarter of 2025 benefited EBITDA. Lower volumes in the first six months of 2025 relative to the first six months of 2024 were partially offset by increased income from our equity investments.

*Ethylene Raw Materials*—In Europe, naphtha is the primary raw material for our ethylene production and represented approximately 60% to 70% of the raw materials used in the second and first quarter of 2025, and the first six months of 2025 and 2024.

The following table sets forth selected financial information for the O&P-EAI segment including Income (loss) from equity investments, which is a component of EBITDA:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| Sales and other operating revenues | $2704 | $2600 | $5304 | $5587 |
| Income (loss) from equity investments | 3 | (6) | (3) | (48) |
| EBITDA | 2 | 17 | 19 | 84 |

---

**Revenue**—Revenues increased by $104 million, or 4%, in the second quarter of 2025 compared to the first quarter of 2025 and decreased by $283 million, or 5%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—Favorable foreign exchange impacts resulted in a revenue increase of 7%. Higher volumes resulted in a revenue increase of 6% primarily due to higher demand. These increases were offset by lower average sales prices primarily as a result of a decrease in the price of naphtha which drove a 9% decrease in revenue.

*First six months of 2025 versus first six months of 2024*—Lower average sales prices primarily as a result of a decrease in the price of naphtha drove a 4% decrease in revenue. Lower volumes resulted in a decrease of 2% due to lower demand and unplanned downtime. Favorable foreign exchange impacts resulted in a 1% increase in revenues.

**EBITDA**—EBITDA decreased by $15 million, or 88%, in the second quarter of 2025 compared to the first quarter of 2025 and by $65 million, or 77%, in the first six months of 2025 compared to the first six months of 2024.

During the second quarter of 2025, we recognized a $32 million non-cash impairment charge related to assets held for sale. Also, during the second quarter, in connection with our planned European asset sale, we incurred transaction costs of $10 million.

*Second quarter of 2025 versus first quarter of 2025*—EBITDA decreased largely due to the recognition of the non-cash impairment charge and costs incurred related to our planned European asset disposition. These costs were partially offset by improved olefins results which led to a 288% increase in EBITDA driven by improved cracker margins primarily due to lower feedstock costs.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

*First six months of 2025 versus first six months of 2024*—As noted above, the first six months of 2025 were impacted by non-cash impairment charges and transaction costs. Further, lower polyethylene results led to a 61% decrease in EBITDA driven by lower margins from lower average sales prices. Lower olefins results drove a 48% decrease in EBITDA driven by lower volumes as a result of unplanned downtime. These decreases were partially offset by improved income from equity investments which led to a 55% increase in EBITDA driven by the absence of losses recognized by a Chinese joint venture in the first six months of 2024.

***Intermediates and Derivatives Segment***

**Overview**—EBITDA increased in the second quarter of 2025 relative to the first quarter of 2025 as a result of shutdown costs incurred by our European PO Joint Venture in the first quarter of 2025 and improved intermediate chemicals margins in the second quarter of 2025.

EBITDA decreased in the first six months of 2025 compared to the first six months of 2024 primarily driven by lower oxyfuels and related products margins, the absence of a gain on sale of our EO&D business recognized in the first six months of 2024, and the first quarter of 2025 shutdown costs related to our European PO Joint Venture.

The following table sets forth selected financial information for the I&D segment including Loss from equity investments, which is a component of EBITDA:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| Sales and other operating revenues | $2275 | $2298 | $4573 | $5381 |
| Loss from equity investments |  |  |  | (6) |
| EBITDA | 286 | 94 | 380 | 1106 |

---

**Revenue**—Revenues decreased by $23 million, or 1%, in the second quarter of 2025 compared to the first quarter of 2025 and by $808 million, or 15%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—Lower average sales prices resulted in a 8% decrease in revenue from falling feedstock pricing in intermediate chemicals and low octane values in the U.S. Gulf Coast. Sales volumes increased due to seasonal demand uptick during the summer driving season resulting in a 4% increase in revenue. Favorable foreign exchange impacts resulted in a 3% increase in revenue.

*First six months of 2025 versus first six months of 2024*—Lower average sales prices resulted in a 13% decrease in revenue driven primarily by oxyfuels and related products as a result of lower crude, gasoline crack spreads, and blend premiums. Sales volumes declined resulting in a 2% decrease in revenue due to the second quarter of 2024 sale of our EO&D business and associated production facilities located in Bayport, Texas.

**EBITDA**—EBITDA increased by $192 million, or 204%, in the second quarter of 2025 compared to the first quarter of 2025 and decreased by $726 million, or 66%, in the first six months of 2025 compared to the first six months of 2024.

In May 2024, we sold our U.S. Gulf Coast-based EO&D business along with the production facilities located in Bayport, TX and recognized a pre-tax gain of $293 million during the quarter.

In March 2025, we announced our plans to permanently close the European PO Joint Venture, which resulted in the recognition of $117 million of shutdown costs in the first quarter of 2025.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

*Second quarter of 2025 versus first quarter of 2025*—Intermediate chemicals results led to an EBITDA increase of 64% primarily driven by higher margins from lower feedstock costs as well as a $36 million gain on sale of precious metals. Propylene oxide and derivatives results led to a 20% increase in EBITDA as margins improved on lower feedstock costs. The remaining change was largely driven by costs incurred related to the announced closure of our European PO Joint Venture in the first quarter of 2025.

*First six months of 2025 versus first six months of 2024*—Oxyfuels and related products results declined 30% largely due to margin compression due to lower crude oil prices. The remaining change was due to the recognition of the gain on sale of our EO&D business in 2024 and costs incurred related to the announced closure of our European PO Joint Venture in the first quarter of 2025.

***Advanced Polymer Solutions Segment***

**Overview**—EBITDA decreased in the second quarter of 2025 relative to the first quarter of 2025, primarily due to costs incurred in connection with our Cash Improvement Plan and lower volumes. EBITDA increased in the first six months of 2025 relative to the first six months of 2024, primarily due to higher margins.

The following table sets forth selected financial information for the APS segment:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| Sales and other operating revenues | $917 | $908 | $1825 | $1913 |
| EBITDA | 32 | 46 | 78 | 75 |

---

**Revenue**—Revenues increased by $9 million, or 1%, in the second quarter of 2025 compared to the first quarter of 2025 and decreased by $88 million, or 5%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—Favorable foreign exchange impacts resulted in a revenue increase of 4%. Sales volumes decreased resulting in a 3% decrease in revenue stemming from weaker automotive demand and challenging market conditions.

*First six months of 2025 versus first six months of 2024*—Sales volumes decreased resulting in a 5% decrease in revenue stemming from lower demand. Lower average sales prices resulted in a 1% decrease in revenue. Favorable foreign exchange impacts resulted in a revenue increase of 1%.

**EBITDA**—EBITDA decreased by $14 million or 30% in the second quarter of 2025 compared to the first quarter of 2025 and increased by $3 million or 4% in the first six months of 2025 compared to the first six months of 2024. In April 2025, we announced our Cash Improvement Plan. Costs incurred during the second quarter of 2025 associated with this plan were $8 million.

*Second quarter of 2025 versus first quarter of 2025*—Lower volumes primarily from weaker automotive demand and challenging market conditions resulted in a 15% decrease in EBITDA. The remaining decrease was primarily related to costs incurred related to the Cash Improvement Plan.

*First six months of 2025 versus first six months of 2024*—Results were relatively unchanged as costs incurred related to our Cash Improvement Plan were offset by improved margins related to lower manufacturing costs.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

***Technology Segment***

**Overview**—EBITDA decreased in the second quarter of 2025 compared to the first quarter of 2025, primarily due to lower catalyst margins. EBITDA decreased in the first six months of 2025 compared to the first six months of 2024, primarily due to lower licensing results as the planned pace of global polyolefin capacity additions moderate.

The following table sets forth selected financial information for the Technology segment:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 30,** | **March 31,** | **June 30,** | **June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2025** | **2025** | **2024** |
| Sales and other operating revenues | $137 | $120 | $257 | $351 |
| EBITDA | 33 | 52 | 85 | 202 |

---

**Revenue**—Revenues increased by $17 million, or 14%, in the second quarter of 2025 compared to the first quarter of 2025 and decreased by $94 million, or 27%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—Favorable foreign exchange impact resulted in an 8% increase in revenues. Higher catalyst volumes resulted in a 5% increase in revenues driven by improved demand relative to prior quarter. Higher licensing revenues resulting from more contracts reaching significant milestones drove a 2% increase in revenues. Lower average catalyst sales price from product mix resulted in a 1% decrease in revenues.

*First six months of 2025 versus first six months of 2024*—Lower licensing revenues resulting from recognition of revenue on fewer contracts drove a 24% decrease in revenues. Lower catalyst volume resulted in a 3% decrease in revenues due to continued lower polymer end use demand. Lower average catalyst sales price resulted in a 1% decrease in revenues. Favorable foreign exchange impact resulted in a 1% increase in revenues.

**EBITDA**—EBITDA decreased by $19 million, or 37%, in the second quarter of 2025 compared to the first quarter of 2025 and by $117 million, or 58%, in the first six months of 2025 compared to the first six months of 2024.

*Second quarter of 2025 versus first quarter of 2025*—Lower catalyst margins resulted in a 56% decrease in EBITDA due to increased costs. Higher catalyst sales volumes driven by improved demand resulted in a 10% increase in EBITDA. Favorable foreign exchange impact resulted in an 8% EBITDA increase.

*First six months of 2025 versus first six months of 2024*—Licensing results led to a 42% decrease in EBITDA as fewer contracts with lower average values reached significant milestones. Lower catalyst margins as a result of unfavorable product mix and higher operating cost from increased maintenance resulted in a 13% decrease in EBITDA.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

 **FINANCIAL CONDITION**

The following table summarizes operating, investing and financing cash flow activities:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| **<u>Millions of dollars</u>** | **2025** | **2024** |
| Cash provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $(228) | $1234 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (934) | (823) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing activities | (598) | (893) |

---

**Operating Activities**—Cash used in operating activities of $228 million in the first six months of 2025 primarily reflected earnings adjusted for non-cash items, $384 million of tax payments which includes $235 million U.S. Federal corporate income tax payments deferred from 2024 into 2025 under Hurricane Beryl disaster relief, and a $433 million change in Accounts payable which was driven by the timing of payments.

Cash provided by operating activities of $1,234 million in the first six months of 2024 primarily reflected earnings adjusted for non-cash items and cash activities primarily related to Accounts receivable, Inventories and Accounts payables. Increased Accounts receivable and Inventories of $604 million and $335 million, respectively, were associated with higher volumes sold to align with demand, coupled with timing of receipts. The increase of $373 million in Accounts payable was primarily driven by timing of payments and higher raw material costs.

**Investing Activities**—Capital expenditures in the first six months of 2025 and 2024 totaled $1,022 million and $967 million, respectively, of which approximately 70% and 80%, respectively, support sustaining maintenance such as turnaround activities at several sites as well as other plant health, safety and environmental projects. The remaining expenditures support profit-generating growth projects.

In June 2025, foreign currency contracts with an aggregate notional value of €200 million expired. Upon settlement of these foreign currency contracts, we paid €200 million ($234 million at the expiry spot rate) to our counterparties and received $225 million from our counterparties. Additionally, in March 2025 we received $59 million upon termination and cash settlement of our cross-currency interest rate swaps, designated as net investment hedges, maturing in 2025 and 2030.

In the second quarter of 2024 we sold our EO&D business for $700 million and invested approximately $500 million to acquire a 35% stake in the NATPET joint venture in Saudi Arabia.

**Financing Activities**—We made dividend payments totaling $878 million and $846 million in the first six months of 2025 and 2024, respectively. Additionally, we made payments of $201 million and $75 million to repurchase outstanding ordinary shares in the first six months of 2025 and 2024, respectively.

In May 2025, we issued $500 million of 6.150% guaranteed notes due 2035. Net proceeds from the sale of the notes are used for general corporate purposes, including the repayment of our 2025 Notes later in the year.

In February 2024, we issued $750 million of 5.5% guaranteed notes due 2034. In March 2024, we repaid the $775 million remaining of outstanding principal on our 5.75% senior notes due 2024.

For additional detail regarding these debt transactions see Note 8 to the Consolidated Financial Statements.

In April 2024, foreign currency contracts with an aggregate notional value of €784 million expired. Upon settlement of these foreign currency contracts, which were designated as cash flow hedges, we paid €784 million ($835 million at the expiry spot rate) to our counterparties and received $849 million from our counterparties.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Liquidity and Capital Resources**

*Overview*

We plan to fund our working capital, capital expenditures, debt service, dividends and other cash requirements with our current available liquidity and cash from operations, which could be affected by general economic, financial, competitive, legislative, regulatory, business and other factors, many of which are beyond our control.

Debt repayment, and the purchase of shares under our share repurchase authorization, may be funded from cash and cash equivalents, cash from short-term investments, cash from operating activities, proceeds from the issuance of debt, or a combination thereof.

As part of our overall capital allocation strategy, we plan to provide returns to shareholders in the form of dividends and share repurchases. Barring any significant or unforeseen business challenges, mergers or acquisitions, over the long-term, we are targeting shareholder returns of 70% of free cash flow, defined as net cash provided by operating activities less capital expenditures. We intend to continue to declare and pay quarterly dividends, including a third quarter 2025 dividend of $1.37 per share. We have a goal of increasing the dividend over time, after giving consideration to our cash balances and expected results from operations. Our focus on funding our dividends while remaining committed to an investment grade balance sheet continues to be the foundation of our capital allocation strategy.

*Cash Improvement Plan*

In April 2025, to address ongoing macroeconomic volatility, we announced a Cash Improvement Plan. The plan now targets a $600 million run-rate in annualized savings for 2025. The Cash Improvement Plan includes three initiatives: (1) deferral of $200 million of capital spending; (2) $200 million net reduction in Accounts receivable, Inventory and Accounts payable; and (3) fixed cost reductions of $200 million, excluding one-time implementation costs estimated to be less than $50 million. We will continue to prioritize capital spending on maintenance and certain growth projects. The net reduction in Accounts receivable, Inventory and Accounts payable and fixed cost reductions are relative to our internal 2025 plan. Fixed cost reductions may be achieved through contract changes, reductions in employees and employee-related expenses or other means. As of June 30, 2025, we incurred $20 million in costs associated with the Cash Improvement Plan.

*Capital Budget*

In 2025, we plan to invest approximately $1.7 billion in capital expenditures. Approximately $1.2 billion of the budget is planned for sustaining maintenance, with the remaining budget supporting profit-generating growth projects. While we continue to invest in *MoReTec-*1 as planned, we are delaying construction to expand our propylene production capacity at our Channelview Complex (Flex-2) and delaying other capital projects to preserve capital during the cycle downturn. In 2026, we plan on investing up to $1.4 billion in capital expenditures.

*Proposed Sale of Certain European Assets*

In June 2025, we entered into an agreement for the sale of select olefins & polyolefins assets and the associated business in Europe. The sites to be sold have been part of the previously announced European strategic assessment and are located in Berre l'Etang (France), Münchsmünster (Germany), Carrington (United Kingdom), and Tarragona (Spain). In connection with the sale, we anticipate making a cash contribution of approximately $300 million to the sold asset group prior to closing the transaction. The transaction is expected to close in the first half of 2026.

*Cash and Liquid Investments*

As of June 30, 2025, we had Cash and cash equivalents totaling $1,700 million, which includes $487 million in jurisdictions outside of the U.S., which is largely held within the United Kingdom. There are currently no legal or economic restrictions that would materially impede our transfers of cash.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

*Credit Arrangements*

As of June 30, 2025, we had total debt, including current maturities, of $11,825 million. Additionally, we had $184 million of outstanding letters of credit, bank guarantees and surety bonds issued under uncommitted credit facilities.

We had total unused availability under our credit facilities of $4,650 million as of June 30, 2025, which included the following:

&nbsp;&nbsp;&nbsp;&nbsp;• $3,750 million under our $3,750 million Senior Revolving Credit Facility. This facility backs our $2,500 million commercial paper program. Availability under the facility is net of outstanding borrowings, outstanding letters of credit provided under the facility and notes issued under our commercial paper program. As of June 30, 2025, we had no outstanding commercial paper and no borrowings or letters of credit outstanding under this facility; and

&nbsp;&nbsp;&nbsp;&nbsp;• $900 million under our $900 million U.S. Receivables Facility. Availability under this facility is subject to a borrowing base of eligible receivables, which is reduced by outstanding borrowings and letters of credit, if any. As of June 30, 2025, we had no borrowings or letters of credit outstanding under this facility. In May 2025, we extended the term of the facility to June 2026 in accordance with the terms of the agreement.

At any time and from time to time, we may repay or redeem our outstanding debt, including purchases of our outstanding bonds in the open market, through privately negotiated transactions or a combination thereof, in each case using cash and cash equivalents, cash from our short-term investments, cash from operating activities, proceeds from the issuance of debt or proceeds from asset divestitures. Any repayment or redemption of our debt will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. In connection with such repurchases or redemptions, we may incur cash and non-cash charges, which could be material in the period in which they are incurred.

*Share Repurchases*

In May 2025, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares through November 23, 2026, which superseded any prior repurchase authorizations. Our share repurchase authorization does not have a stated dollar amount, and purchases may be made through open market purchases, private market transactions or other structured transactions. Repurchased shares could be retired or used for general corporate purposes, including for various employee benefit and compensation plans. The maximum number of shares that may yet be purchased is not necessarily an indication of the number of shares that will ultimately be purchased. In the first six months of 2025, we purchased approximately 3.0 million shares under our share repurchase authorizations for $201 million.

As of July 30, 2025, we had approximately 34.0 million shares remaining under the current authorization. The timing and amounts of additional shares repurchased, if any, will be determined based on our evaluation of market conditions and other factors, including any additional authorizations approved by our shareholders. For additional information related to our share repurchase authorizations, see Note 12 to the Consolidated Financial Statements.

**CURRENT BUSINESS OUTLOOK**

In the third quarter, we expect North American integrated polyethylene margins to improve due to the completion of planned maintenance in April and increased prices supported by solid domestic demand and stronger export volumes. In Europe, steady seasonal demand and favorable feedstock costs are expected to continue. Ongoing capacity rationalizations across the region should help to balance regional supply and demand. Oxyfuels margins are expected to remain low for the remainder of the summer season. We continue to carefully evaluate potential risks and opportunities associated with evolving tariffs and global trade flows.

To align with global demand and our planned maintenance, we expect third quarter operating rates of 85% for our O&P-Americas assets, 75% for our European O&P-EAI assets and 80% for our I&D assets.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**ACCOUNTING AND REPORTING CHANGES**

For a discussion of the potential impact of new accounting pronouncements on the Consolidated Financial Statements, see Note 2 to the Consolidated Financial Statements.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**CAUTIONARY STATEMENT FOR THE PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995**

This report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"). You can identify our forward-looking statements by the words "anticipate," "estimate," "believe," "continue," "could," "intend," "may," "plan," "potential," "predict," "should," "will," "expect," "objective," "projection," "forecast," "goal," "guidance," "outlook," "effort," "target" and similar expressions.

We based forward-looking statements on our current expectations, estimates and projections of our business and the industries in which we operate. We caution you that these statements are not guarantees of future performance. They involve assumptions about future events that, while made in good faith, may prove to be incorrect, and involve risks and uncertainties we cannot predict. Our actual outcomes and results may differ materially from what we have expressed or forecast in the forward-looking statements. Any differences could result from a variety of factors, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;• the cost of raw materials represents a substantial portion of our operating expenses, and energy costs generally follow price trends of crude oil, natural gas liquids and/or natural gas; price volatility can significantly affect our results of operations and we may be unable to pass raw material and energy cost increases on to our customers due to the significant competition that we face, the commodity nature of our products and the time required to implement pricing changes;

&nbsp;&nbsp;&nbsp;&nbsp;• our operations in the United States ("U.S.") have benefited from low-cost natural gas and natural gas liquids; decreased availability of these materials (for example, from their export or regulations impacting hydraulic fracturing in the U.S.) could reduce the current benefits we receive;

&nbsp;&nbsp;&nbsp;&nbsp;• if crude oil prices are low relative to U.S. natural gas prices, we could see less benefit from low-cost natural gas and natural gas liquids and it could have a negative effect on our results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;• industry production capacities and operating rates may lead to periods of oversupply and low profitability;

&nbsp;&nbsp;&nbsp;&nbsp;• we may face unplanned operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failures, unscheduled downtime, supplier disruptions, labor shortages, strikes, work stoppages or other labor difficulties, transportation interruptions, spills and releases and other environmental incidents) at any of our facilities, which would negatively impact our operating results;

&nbsp;&nbsp;&nbsp;&nbsp;• changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate could increase our costs through tariffs or otherwise, limit or disrupt trade, restrict our operations and reduce our operating results;

&nbsp;&nbsp;&nbsp;&nbsp;• our ability to execute our organic growth plans may be negatively affected by our ability to complete projects on time and on budget;

&nbsp;&nbsp;&nbsp;&nbsp;• the successful outcome of any planned sale of our assets, or our ability to acquire or dispose of product lines or businesses could disrupt our business and harm our financial condition;

&nbsp;&nbsp;&nbsp;&nbsp;• uncertainties associated with worldwide economies could create reductions in demand and pricing, as well as increased counterparty risks, which could reduce liquidity or cause financial losses resulting from counterparty default;

&nbsp;&nbsp;&nbsp;&nbsp;• the negative outcome of any legal, tax and environmental proceedings or changes in laws or regulations regarding legal, tax and environmental matters may increase our costs, reduce demand for our products, or otherwise limit our ability to achieve savings under current regulations;

&nbsp;&nbsp;&nbsp;&nbsp;• any loss or non-renewal of favorable tax treatment under tax agreements or tax treaties, or changes in tax laws, regulations or treaties, may substantially increase our tax liabilities;

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;• we may be required to reduce production or idle certain facilities because of the cyclical and volatile nature of the supply-demand balance in the chemical and refining industries, which would negatively affect our operating results;

&nbsp;&nbsp;&nbsp;&nbsp;• we rely on continuing technological innovation, and an inability to protect our technology, or others' technological developments could negatively impact our competitive position;

&nbsp;&nbsp;&nbsp;&nbsp;• we have significant international operations, and fluctuations in exchange rates, valuations of currencies and our possible inability to access cash from operations in certain jurisdictions on a tax-efficient basis, if at all, could negatively affect our liquidity and our results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;• we are subject to the risks of doing business at a global level, including wars, terrorist activities, political and economic instability and disruptions and changes in governmental policies, which could cause increased expenses, decreased demand or prices for our products and/or disruptions in operations, all of which could reduce our operating results;

&nbsp;&nbsp;&nbsp;&nbsp;• if we are unable to achieve our emission reduction, circularity, or other sustainability targets, it could result in reputational harm, changing investor sentiment regarding investment in our stock or a negative impact on our access to and cost of capital;

&nbsp;&nbsp;&nbsp;&nbsp;• our ability to execute and achieve expected results of our value enhancement program and cash improvement plan;

&nbsp;&nbsp;&nbsp;&nbsp;• if we are unable to comply with the terms of our credit facilities, indebtedness and other financing arrangements, those obligations could be accelerated, which we may not be able to repay; and

&nbsp;&nbsp;&nbsp;&nbsp;• we may be unable to incur additional indebtedness or obtain financing on terms that we deem acceptable, including for refinancing of our current obligations; higher interest rates and costs of financing would increase our expenses.

Any of these factors, or a combination of these factors, could materially affect our future results of operations and the ultimate accuracy of the forward-looking statements. Our management cautions against putting undue reliance on forward-looking statements or projecting any future results based on such statements or present or prior earnings levels.

All subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section and any other cautionary statements that may accompany such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements.

**Item 3**.&nbsp;&nbsp;&nbsp;&nbsp;**QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

Our exposure to market and regulatory risks is described in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2024. Our exposure to such risks has not changed materially in the six months ended June 30, 2025.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;CONTROLS AND PROCEDURES**

As of June 30, 2025, with the participation of our management, our Chief Executive Officer (principal executive officer) and our Chief Financial Officer (principal financial officer) carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the "Act"), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Act). Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2025.

There have been no changes in our internal controls over financial reporting, as defined in Rule 13a-15(f) of the Act, in the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

 **PART II. OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;LEGAL PROCEEDINGS**

*Environmental Matters*

From time to time, we and our joint ventures receive notices or inquiries from government entities regarding alleged violations of environmental laws and regulations pertaining to, among other things, the disposal, emission and storage of chemical and petroleum substances, including hazardous wastes. U.S. Securities and Exchange Commission rules require disclosure of certain environmental matters when a governmental authority is a party to the proceedings and the proceedings involve potential monetary sanctions that we reasonably believe could exceed $300,000. The matters below are disclosed solely pursuant to that requirement and we do not believe that any of these proceedings will have a material impact on the Company's Consolidated Financial Statements.

In April 2025, the State of Texas filed suit against Equistar Chemicals, LP, a subsidiary of LyondellBasell N.V., in Travis County District Court seeking civil penalties and injunctive relief for violations of the Texas Clean Air Act related to several alleged emission events between May 2018 and April 2021.

In May 2025, the Texas Commission on Environmental Quality issued a proposed Agreed Order to Equistar Chemicals, L.P., a subsidiary of LyondellBasell N.V., to resolve alleged air permitting exceedances at the La Porte Complex between 2020 and 2022.

*Litigation and Other Matters*

Information regarding our litigation and legal proceedings can be found in Note 11 to the Consolidated Financial Statements, which is incorporated into this Item 1 by reference.

**Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;RISK FACTORS**

There have been no material changes to the risk factors associated with our business previously disclosed in "Item 1A. Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** |
| **Period** | **Total Number<br>of Shares <br>Purchased** | **Average Price<br>Paid per Share** | **Total Number of<br>Shares Purchased<br>as Part of Publicly<br>Announced Plans<br>or Authorizations** | **Maximum Number<br>of Shares That May Yet<br>Be Purchased Under the<br>Plans or Authorizations** |
| April 1 - April 30, 2025 | 1552339 | $58.09 | 1552339 | 28767915 |
| May 1 - May 22, 2025 |  | $— |  | 28767915 |
| May 23 - May 31, 2025 |  | $— |  | 34042250 |
| June 1 - June 30, 2025 |  | $— |  | 34042250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 1552339 | $58.09 | 1552339 |  |

---

On May 23, 2025, our shareholders approved a share repurchase authorization of up to 34,042,250 shares of our ordinary shares, through November 23, 2026, which superseded any prior repurchase authorizations. The maximum number of shares that may yet be purchased is not necessarily an indication of the number of shares that will ultimately be purchased.

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;MINE SAFETY DISCLOSURES**

Not applicable.

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION**

During the three months ended June 30, 2025, none of our Section 16 officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**Item 6. &nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 4.1 | <u>[Officer's Certificate of LYB International Finance III, LLC relating to the 6.150% Guaranteed Notes due 2035, dated as of May 15, 2025 (incorporated by reference to Exhibit 4.3 to our Current Report on Form 8-K filed with the SEC on May 15, 2025).](https://www.sec.gov/Archives/edgar/data/1489393/000110465925049424/tm2514631d1_ex4-3.htm)</u> |
| 4.2 | <u>[Form of LYB International Finance III, LLC's 6.150% Guaranteed Notes due 2035 (included in Exhibit 4.](https://www.sec.gov/Archives/edgar/data/1489393/000110465925049424/tm2514631d1_ex4-3.htm)[1](https://www.sec.gov/Archives/edgar/data/1489393/000110465925049424/tm2514631d1_ex4-3.htm)[).](https://www.sec.gov/Archives/edgar/data/1489393/000110465925049424/tm2514631d1_ex4-3.htm)</u> |
| 10.1 | <u>[Seventh Amendment to Receivables Purchase Agreement, dated as of May 29, 2025, among Lyondell Chemical Company, as servicer, LYB Receivables LLC, as seller, the conduit purchasers, related committed purchasers, LC participants and purchaser agents party thereto, the other parties thereto and Mizuho Bank, Ltd., as Administrator and LC Bank (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on May 30, 2025).](https://www.sec.gov/Archives/edgar/data/1489393/000148939325000031/exhibit101_2025may8-k.htm)</u> |
| 10.2 | <u>[Put Option Letter Agreement between LyondellBasell Industries Holdings B.V. and AEQ Amethyst B.V. (including the form of Sale and Purchase Agreement as Schedule 1 thereto) (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on June 5, 2025).](https://www.sec.gov/Archives/edgar/data/1489393/000148939325000033/exhibit101elephant-putopti.htm)</u> |
| 31.1\* | <u>[Certification of Principal Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934](a2025q2exhibit311.htm)</u> |
| 31.2\* | <u>[Certification of Principal Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934](a2025q2exhibit312.htm)</u> |
| 32\*\* | <u>[Certifications pursuant to 18 U.S.C. Section 1350](a2025q2exhibit32.htm)</u> |
| 101.INS\* | XBRL Instance Document–The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH\* | XBRL Schema Document |
| 101.CAL\* | XBRL Calculation Linkbase Document |
| 101.DEF\* | XBRL Definition Linkbase Document |
| 101.LAB\* | XBRL Labels Linkbase Document |
| 101.PRE\* | XBRL Presentation Linkbase Document |
| 104\* | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |

---

\* Filed herewith

\*\* Furnished herewith

------

<u>[Table of](#i3e1ae353f0754b77ac381f1934c5c699_7)[Contents](#i3e1ae353f0754b77ac381f1934c5c699_7)</u>

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | **LYONDELLBASELL INDUSTRIES N.V.** |
| Date: | August 1, 2025 | |
| | | *<u>/s/ Matthew D Hayes</u>* |
| | | Matthew D. Hayes |
| | | Senior Vice President, |
| | | Chief Accounting Officer |
| | | *(Principal Accounting Officer)* |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION**

I, Peter Vanacker, certify that:

1. I have reviewed this quarterly report on Form 10-Q of LyondellBasell Industries N.V.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

August 1, 2025

---

| |
|:---|
| *<u>/s/ Peter Vanacker</u>* |
| Peter Vanacker |
| Chief Executive Officer |
| *(Principal Executive Officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION**

I, Agustin Izquierdo, certify that:

1. I have reviewed this quarterly report on Form 10-Q of LyondellBasell Industries N.V.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

August 1, 2025

---

| |
|:---|
| *<u>/s/ Agustin Izquierdo</u>* |
| Agustin Izquierdo |
| Executive Vice President and |
| Chief Financial Officer |
| *(Principal Financial Officer)* |

---

## Ex-32

**Exhibit 32**

**CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In connection with the Quarterly Report of LyondellBasell Industries N.V. (the Company) on Form 10-Q for the period ended June 30, 2025, as filed with the U.S. Securities and Exchange Commission on the date hereof (the Report), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

(1) The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 1, 2025

---

| |
|:---|
| *<u>/s/ Peter Vanacker</u>* |
| Peter Vanacker |
| Chief Executive Officer |
| *(Principal Executive Officer)* |
| *<u>/s/ Agustin Izquierdo</u>* |
| Agustin Izquierdo |
| Executive Vice President and |
| Chief Financial Officer |
| *(Principal Financial Officer)* |

---

<br>